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ABSTRACT
STRUCTURAL ANALYSIS OF PROTEINS BY COVALENT
LABELING AND MASS SPECTROMETRIC DETECTION
FEBRUARY 2014
YUPING ZHOU
B.Sc., ZHEJIANG UNIVERSITY
M.Sc., ZHEJIANG UNIVERSITY
Ph.D., UNIVERSITY OF MASSACHUSETTS AMHERST
Directed by: Richard W. Vachet, Ph. D.

Covalent labeling and mass spectrometry are seeing increased use together as a way to
obtain insight into the 3-dimensional structure of proteins and protein complexes. Several amino
acid specific (e.g., diethylpyrocarbonate) and non-specific (e.g., hydroxyl radicals) labeling
reagents are available for this purpose. Diethylpyrocarbonate (DEPC) is a promising labeling
reagent because it can potentially probe up to 30% of the residues in the average protein and
gives only one reaction product, thereby facilitating mass spectrometric analysis. It was recently
reported, though, that DEPC modifications are labile for some amino acids.
This dissertation focuses on the improvement of diethylpyrocarbonate (DEPC)-based
covalent labeling for increased protein structural resolution. The number of DEPC modified
residues and, thus, protein structural information, can be significantly increased by decreasing
the time between the covalent labeling reaction and the mass spectrometric analysis. This is most
effectively accomplished using short (e.g., 2 h) proteolytic digestions with enzymes such as
immobilized chymotrypsin or Glu-C rather than using methods (e.g., microwave or ultrasonic
irradiation) that accelerate proteolysis in other ways. Besides, Cys residues that form disulfide
bonds appear to be modified by DEPC as well. We demonstrate that disulfide linked Cys
vi

residues are not actually reactive with DEPC but, instead, once reduced, free Cys residues can
capture a carbethoxy group from other modified amino acids via a solution-phase reaction that
can occur during the protein digestion step. This “scrambling” of carbethoxy groups decreases
the amount of modification observed at other residues and can potentially provide incorrect
protein structural information. Fortunately, label scrambling can be completely avoided by
alkylating the free thiols after disulfide reduction.
We also developed novel methods as indicators of protein structural integrity using
isotopically encoded labeling reagent Tandem Mass Tags. Because most covalent labels are
relatively large, steps must be taken to ensure the structural integrity of the modified protein
during the labeling reactions so that correct structural information can be obtained. Measuring
labeling kinetics is a reliable way to ensure that a given labeling reagent does not perturb a
protein’s structure, but obtaining such kinetic information is time and sample intensive because it
requires multiple liquid chromatography (LC)–MS experiments. Here we present a new strategy
that uses isotopically encoded labeling reagents to measure labeling kinetics in a single LC–MS
experiment. We illustrate this new strategy by labeling solvent-exposed lysine residues with
commercially available tandem mass tags. After tandem MS experiments, these tags allow the
simultaneous identification of modified sites and determination of the reaction rates at each site
in a way that is just as reliable as experiments that involve multiple LC–MS measurements.
This improved technique is then applied to study the structural change of proteins that
undergo forced degradation. Because covalent labeling combined with MS can be used to
monitor conformational changes of proteins, it can also be applied to study structural changes of
proteins after exposure to degradation conditions. β2m was used as a model protein to examine
the potential of this method. Forced degradation studies using thermal and oxidative conditions
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were carried out. Covalent modification patterns of the protein show clear differences under
these degradation conditions as compared to the native protein. The general trend that we found
was that less modification was observed for both thermal and oxidative condition, indicating that
aggregation could occur at higher temperatures or in the presence of hydrogen peroxide. Size
exclusion chromatography confirmed that there was dimer formation during the forced
degradation conditions, which is consistent with the covalent labeling data. This method could be
applied to other systems to study degradation caused structural changes of proteins as it is a fast
and relatively simple approach.
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CHAPTER 1
STRUCTURAL ANALYSIS OF PROTEINS BY COVALENT LABELING AND MASS
SPECTROMETRIC DETECTION
This chapter is part of a paper published as: Zhou, Y., Dong, J and Vachet, R. W. (2011)
Electron Transfer Dissociation of Modified Peptides and Proteins. Curr. Pharm. Biotechnol.12,
1558-1567.

1.1 Analysis of Proteins by Mass Spectrometry
Mass spectrometry (MS) is an analytical technique that measures the mass to charge ratio
(m/z) of analytes. Because MS measures an intrinsic property of a molecule, it is used in an
amazingly wide range of applications. Although its beginning dates back to the early days of last
century, MS started to play an increasingly significant role in the biological sciences in the 1980s.
The main reason was that mass spectrometers require charged, gaseous molecules for analysis,
and biomolecules, which are usually large and polar, were not easily transferred into the gas
phase and ionized until electrospray ionization (ESI) [1] and matrix-assisted laser desorption
ionization (MALDI) [2] were developed. Besides, advances were also made in other areas, such
as sample preparation for MS and software algorithms. Due to all these efforts, MS has played an
ever increasing role in various research areas.
Since MS measures the m/z of analytes, it can be used to detect the molecular weight of
intact proteins. For this purpose, electrospray is often the method of choice, although MALDI
can also be used for MW determination of proteins. Proteins need to be free of detergents and
salts for optimal analysis by MS. Salt removal is usually accomplished by reversed-phase
chromatography or more easily using a desalting column. Formic acid or acetic acid can be
added to facilitate protonation of proteins during ESI analyses. Identification of intact proteins
from cell lysates by molecular weight alone is difficult.

1

With the development of tandem mass spectrometry (MS/MS) [3], peptide and protein
sequence information can be determined by interpreting the data resulting from fragmentation of
peptides and intact proteins. This can be done by two means: bottom-up sequencing and topdown sequencing. For bottom-up sequencing, a protein is digested into peptide fragments first,
then a given peptide out of a mixture is isolated or separated from the other ions in the mass
spectrometer and is then dissociated by either collisions with an inert gas as in collision-induced
dissociation (CID), or the transfer of electrons as in electron transfer or electron capture
dissociation (ETD or ECD). The resulting fragments are mass analyzed, producing a tandem
mass spectrum. This approach can be extended to multiple isolation and fragmentation stages
(MSn) when using trapping type mass analyzers. For top-down sequencing, the whole protein
without proteolysis is injected for fragmentation. Tandem mass spectra are usually interpreted
with software assistance, or matched against databases directly.
Tandem MS if often used for protein identification with the help of database searching.
Proteins can be digested into peptide fragments, and then the measurement of m/z of the peptides
alone (peptide mass fingerprinting) [4] or the measurement the tandem mass spectra of the
peptides [5] can be used to match against protein databases for protein identification. In the
peptide mass fingerprinting approach, the measured peptide m/z values are obtained and
compared with the theoretically expected peptide masses from the in silico digestion of the
proteins in the database. The proteins can be ranked according to the number of peptide matches.
Peptide mass fingerprinting is used for the rapid identification of a single protein component, and
protein sequences need to be in the database. For more accurate identification or for the
identification of multiple proteins at the same time, proteins can be digested and “dissociated” in
silico and can then be searched against experimentally measured tandem MS data obtained on
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peptides from the proteins of interest. Tandem mass spectra contain structural information
related to the sequence of the peptide, rather than only its mass. Thus, the results are more
reliable and can be used to identify multiple proteins.

1.2 Higher Order Structural Analysis of Proteins by Covalent Labeling and Mass Spectrometry
As mentioned above, MS and MS/MS experiments are major tools used in protein
identification. The inherent advantages of MS, including sensitivity, specificity, and speed have
led to the technique being explored for use in the higher order (i.e. secondary and tertiary)
structural analysis of proteins. While the other methods, such as NMR and X-ray crystallography
are the most important techniques to study protein structures, there are some limitations of these
methods, e.g. some proteins are not amenable to these methods due to size, conformational
flexibility, aggregation propensity, inability to crystallize, or limited sample amount. MS alone
cannot provide direct information about a protein’s 3D structure in solution, and therefore must
be used with labeling techniques such as H/D exchange [6-16], crosslinking [17-27], covalent
labeling [28-36], and noncovalent labeling [37-39]. Alternatively, ion mobility mass
spectrometry can also be used to study protein structure in the gas phase [40-42], and
connections between gas-phase and solution phase structures allow ion mobility to say
something about different protein forms that exist in solution [43-48].
H/D exchange approaches use deuterium as a labeling reagent and can provide information
about protein dynamics and structure [6-16]. Labile backbone amide hydrogens in a protein will
exchange with deuteriums when the protein is placed in a D2O solution. In disordered regions of
the protein that lack stable hydrogen-bonding, rapid H/D exchange will occur. Tightly folded
parts are much more protected, resulting in slow isotope exchange that is mediated by the
structural dynamics of the protein. Once the incorporation of the isotope label is complete, the
3

reaction is quenched at low pH and 0 ºC and quickly analyzed to minimize back exchange. The
subsequent increase in protein mass over time is measured with MS (see figure 1.1). Mass
analysis of an intact protein can provide information about the global changes in protein structure
and stability. Proteolytic digestion along with LC-MS of the resulting peptides can yield
information on the H/D exchange behavior of specific regions within the protein. H/D exchange
with MS has been used to study the protein assemblies, protein dynamics, protein
unfolding/refolding, and protein binding interactions. H/D exchange provides useful information
about proteins and protein dynamics that cannot be easily obtained with other techniques. Backexchange and scrambling of deuterium are very possible in using this method, and great care
must be taken to avoid it. Besides, H/D exchange cannot provide side-chain information, which
is very import in understanding protein interactions with ligands and other proteins.

Figure 1.1 Schematic figure for H/D exchange and mass spectrometry
4

Protein cross-linking uses a reactive probe to link two different proteins or two sites on the
same protein together to check protein-protein interactions [17-27]. The location of the created
cross-links imposes a distance constraint on the location of the respective side chains so that
conclusions about the 3D structure of the protein or a protein complex can be drawn. Different
cross-linkers appropriate for a given protein or protein complex can be selected based on arm
type, arm length, specificity, cleavability and so on. After the cross-linking reaction, protein
samples can be analyzed by MS. Bottom-up sequencing is more commonly used in cross-linking
experiments to identify cross-linked sites

(see figure 1.2). Identification of cross-linking

products, however, can be hampered by the complexity of the cross-linking reaction mixture, and
distinguishing cross-linked peptides and thus finding interaction sites can be difficult.

Figure 1.2 Schematic figure for cross-linking combined with mass spectrometry
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Ion mobility has been recently coupled to MS to provide a new dimension in the analysis
of biomolecules, with ion mobility separating ions according to differences in size and shape.
This technique can be used for analyzing complex mixtures based on different mobilities in an
electric field, and to characterize gas-phase ions through measurement of the collision cross
section and comparison with molecular modeling. Increasing evidence has been provided that
protein conformations in the gas phase mirror those in the solution phase, especially over short
period of time. For example, studies were carried out to show that under controlled ESI
conditions, protein conformations can be preserved upon ionization, and gas-phase ions preserve
the conformational properties of structures present in the solution phase over the time that they
exist within the mass spectrometer [49]. Besides, cross-sections estimated for the lower ESIgenerated charge states of several proteins compare well with those calculated from X-ray crystal
structures [50, 51]. Therefore, information provided by ion mobility MS can shed light on the
structure of the protein in the solution phase. Whether gas phase structure represents the solution
phase structure or isomerization take place during the evaporation and desolvation process is still
an area of active research.
Mass spectrometry has also being used in combination with covalent labeling reactions to
study protein structure and protein-protein interaction [28]. The covalent labeling methods can
map protein structure and interactions by measuring the differential reactivity of amino acid side
chains. The reactivity of amino acids in proteins is usually controlled by the solvent accessible
surface area (SASA).Therefore, it can provide information about protein surface structure. In
comparison to H/D exchange, covalent labeling does not suffer much from label back-exchange
or scrambling, and it also provides structural information about amino acid side chains, making it
complementary to H/D exchange. Covalent labeling also has some similarities to chemical cross-
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linking in that it covalently modifies amino acid side chains. In covalent labeling experiments,
however, only a single polypeptide chain is modified, making mass spectral and data analyses
more straightforward (see figure 1.3).

Figure 1.3 Bottom-up process of covalent labeled proteins combined with MS

There are two general types of covalent labeling reagents – those that modify many
different amino acids (e.g. hydroxyl radicals [29-34, 52-54] and L-photoleucine[55]), and those
that react with specific amino acids (e.g. succinimides that react with lysine residues [28, 56,
57]). Hydroxyl radicals are one of the most popular reagents for footprinting and structural MS.
It has a van der Waals surface similar to water and therefore can provide very high resolution
structural information. Hydroxyl radicals can react with solvent accessible side-chain resides,
and the labeling sites can be easily detected by MS based on the mass shift that occurs upon
modification. Generally speaking, hydroxyl radicals can modify ~65 % of the sequence of a
7

typical protein, providing protein structure information with good resolution [58]. This technique
is very powerful for detecting interfaces and conformational changes due to protein interactions
by comparing the oxidation behavior of proteins with and without the interaction. For example,
this technique detected the conformational change of the actin binding protein gelsolin after
activation by Ca2+[59]. Hydroxyl radical labeling has also been used to examine protein folding
[34]and protein dynamics [52].Hydroxyl radical mediated protein footprinting is a very
promising structural analysis technique due to its robustness, reproducibility and flexibility. The
major disadvantage of this method is the low reactivity of some residues, such as Gly and Ala,
and low detectability of oxidized products of Ser and Thr. Hence if a peptide contains no probe
site, then no structural information can be obtained [53]. In addition, each amino side chain can
have multiple reaction products, thereby increasing the complexity of the MS analysis.
L-photoleucine was recently reported [55] as a labeling reagent for protein topographic
analysis. Laser photolysis of photoleucine releases nitrogen and produces a highly reactive
singlet carbene. This carbene can react with its immediate molecular cage [60].The modification
sites then can be localized by HPLC-MS/MS after proteolytic digestion. Carbenes are appealing
as chemical labeling reagents, because they appear to probe all amino acids [61]. Besides, this
carbene labeling is fast and irreversible. Although the carbene itself reacts nondiscriminately
with amino acids, studies [55] do suggest a degree of surface bias because of reagent affinity and
orientation.
Amino acid specific labels have been used extensively with MS to study protein structure
and protein-protein/ protein-ligand interactions [28]. Amino acid specific labels include these
that can react with arginine, carboxylic acids, cysteine, histidine, lysine, trypotophan and
tyrosine. For example, acetic andsuccinic anhydride, which can react with lysine residues, have
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been used to characterize the surface topology of proteins. Comparison of the data from labeling
experiments and X-ray crystallographic structure data indicate that selective acylation combined
with mass spectrometric peptide mapping is an efficient approach for the molecular
characterization of surface topology [57]. In most cases, these labeling reactions are irreversible,
and the information obtained from this methodology is complementary to other biophysical
techniques. Because these labels only modify specific amino acid, however, structural
information obtained by this technique might be limited based on the protein structure.
Improvements in developing new amino acid-specific labels or labels that can target different
amino acid side chains at the same time are greatly needed.
Our group has been investigating diethylpyrocarbonate (DEPC) as a multi-residue
labeling reagent because we have found that it can probe up to 30% of the residues in the average
protein, including the N-terminus, His, Lys, Tyr, Ser, Thr and Cys residues [62] (Figure 1.4).
DEPC also generates only one product type, carbethoxylated residues, allowing for
straightforward and sensitive analyses of the modified amino acids. We and others have shown
that DEPC labeling can provide useful structural information for proteins and protein-protein
interactions [62-68]. Due to DEPC’s molecular size, proteins are typically only labeled at amino
acids that are exposed to solvent on the protein surface. Amino acids that are buried inside the
protein are usually not labeled. Thus, DEPC is particularly useful for studying protein-protein
complexes.
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Figure 1.4 Reactions of Histidine, Lysine, Tyrosine, Serine, and Threonine with DEPC

Structural information obtained from covalent labeling is reliable, though, only if the
structural integrity of a protein is preserved during the reaction. Because most covalent labels are
relatively large compared to deuterium or hydroxyl radicals, for example, they can potentially
distort a protein’s structure upon reaction. Consequently, appropriate checks are required to
ensure that the labeling reaction preserves the protein’s structure and thus provides reliable
information. Several methods, such as circular dichroism (CD) spectroscopy, activity assays, and
10

fluorescence spectroscopy, have been used to check protein structure; however, these methods
are often not sufficient for monitoring the effect of modification on protein structure because
they report on either global structure (e.g. CD) or only a few regions of the protein (e.g.
fluorescence spectroscopy and activity assays). Previously, we have demonstrated that doseresponse curves can be used to reliably detect protein structural changes anywhere in the protein
[62]. Such plots involve measuring the extent of modification at each labeled site to determine
labeling kinetics. Measuring the kinetics of the labeling reactions provides a very sensitive,
although time-consuming, way to monitor any modification-induced structural changes caused
by the covalent labels.
In order to locate the covalent modification sites, tandem MS is used (as shown in figure
1.3). The most commonly used fragmentation technique is collision induced dissociation (CID).
Sometimes CID suffers some disadvantages, though. For example, dissociation during CID is
influenced by amino acid side-chain chemistry. Modifications by covalent labels might alter or
inhibit dissociation, leading to incorrect results [69]. A more recently developed dissociation
technique, electron transfer dissociation (ETD), tends to dissociation ions evenly along the
peptide backbone. The next section will discuss more about ETD and CID for modified peptides
and proteins.
Currently, there are two complementary methods for the mass spectrometry analysis of
proteins: bottom-up and top-down approaches. Figure 1.3 shows the bottom-up sequencing
method. This is the most commonly used method to sequence protein and locate the labeling
sites although top-down sequencing also can be used for this purpose. A combination of bottomup and top-down method, called middle-down sequencing, is also able to identify labeling sites.
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Section 1.4 will discuss more detail about how these different techniques can benefit covalent
labeling experiment.

1.3 ETD vs CID for Modified Peptides and Proteins
Mass spectrometry is the preferred choice for characterizing post-translational
modifications (PTMs) and chemical modifications like covalent labels. Typically, proteins are
enzymatically digested, separated by reversed-phase liquid chromatography, ionized by
electrospray ionization, and then dissociated in the gas phase during MS/MS to generate
sequencing identifying product ions. Most commonly, collision-induced dissociation (CID) is
used to break apart peptide ions, usually at peptide bonds to create b-type and y-type product
ions (Figure 1.5). Successive losses of amino acids to form these b and y ions enable a peptide’s
sequence to be determined.

Figure 1.5 Nomenclature of the product ions generated in the fragmentation of peptide molecules
by tandem mass spectrometry [70].
The same basic approach can also be applied to locate modification sites on peptides;
however, the dissociation chemistry of modified peptide ions is sometimes altered relative to
12

their unmodified counterparts, thereby making it more difficult to obtain sequence information.
To a first approximation, shifts in the mass-to-charge (m/z) ratios of certain product ions should
indicate both the location and the type of modification. Indeed, this approach has been used very
successfully in large-scale characterizations of the phosphoproteome [71, 72], for example.
Despite the success of this approach, CID does have some limitations when it comes to the
analysis of peptides and proteins with certain modifications. Because CID chemistry is
influenced by amino acid side-chains, some modifications can alter or inhibit dissociation along
the peptide backbone. A well-known example of this phenomenon occurs with peptides
phosphorylated at serine or threonine residues. Upon collisional activation, these phosphorylated
peptides eliminate phosphoric acid with minimal associated backbone cleavage. The result is a
tandem mass spectrum that contains limited sequence information and oftentimes no information
about the phosphorylation site [73].
Electron capture dissociation (ECD), which was developed by McLafferty and coworkers [74], is an alternate dissociation technique that is usually not affected by amino acid
modifications. In ECD, peptide ions capture low energy electrons in a magnetic field, and this
process dissociates peptide ions at the N-Cα bond along the peptide backbone, usually giving rise
to c and z• ions (Figure 1.6). A key advantage of this approach for modified peptides is that
labile modifications, such as phosphorylated sites, remain intact, allowing both sequence and
modification site information to be obtained. Unfortunately, ECD can only be performed on very
expensive FT-ICR mass spectrometers.
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Figure 1.6 ETD dissociation scheme of a multiply protonated peptide after electron transfer from
a radical anion to produce c- and z-type ions

An analogous dissociation technique, known as electron-transfer dissociation (ETD) [75],
can be implemented on less expensive, more easily maintained, and more widely accessible mass
spectrometers such as quadrupole ion traps. Moreover, ETD dissociates peptides to produce c
and z• ions while maintaining labile modifications just as in ECD. Unlike ECD, ETD relies on
ion/ion chemistry in which positively-charged peptide ions are reacted in the gas phase with
radical anions such as fluoranthene radicals (Figure 1.6). Being able to dissociate modified
peptide ions on more accessible mass spectrometers, especially ones that are readily coupled
with liquid chromatography, has expanded the ability to characterize modified peptides and
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proteins that are important for understanding a variety of biological processes and for fully
characterizing recombinant therapeutic proteins.
Electron transfer from a radical anion to a positively-charged peptide ion eventually
triggers dissociation into complementary pairs of c- and z- fragment ions[75, 76]. While ETD
has clear advantages when compared to CID for the analysis of modified peptides, the
dissociation efficiency of ETD is sometimes too low when proteins are digested in the standard
manner using trypsin. As a result, ETD can result in fewer total peptides identified during largescale proteomics experiments. This occurs because ETD tends to give less overall sequence
information than CID for the doubly-charged peptides ions that are commonly produced during
tryptic digests. Given the advantages of ETD for the analysis of modified peptides, however,
researchers have turned to other proteases, such as Lys-C or Asp-N, that produce larger peptide
fragments that tend to have three or more charges when subjected to electrospray ionization.
Alternatively, supercharging reagents such as m-nitrobenzyl alcohol have been investigated as
additives to increase the average charges states of peptide ions during electrospray ionization [6].
The production of more highly charged peptide ions (+3 or greater) usually results in very good
ETD dissociation efficiency, and often ETD outperforms CID in terms of sequence coverage and
peptide identifications under such conditions.
In most cases, both CID and ETD can be used to locate the modification sites for peptides
and proteins; however, there are some cases where one of the fragmentation methods causes
incorrect information. For example, CID can cause mis-assignment of oxidative modification site.
Such modifications can change the dissociation pathways of peptide ions. It’s been reported that
oxidation of histidine to 2-oxo-histidine can cause the incorrect assignment of oxidized residues
when more than one oxidized isomer is subjected to tandem mass spectrometry. These spectral
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misinterpretations can be avoided by the following three methods: the first one is to use multiple
stages of MS/MS (MSn); the second one is to use specially-optimized liquid chromatographic
separation conditions; the third one is N-terminal derivatization with sulfobenzoic acid
[69].While the oxidation of histidine leads to the mis-assignment of modification sites, the
oxidative modification to the side chains of sulfur-containing amino acids usually decrease
fragmentation efficiency during CID, making it difficult to obtain sequence information and the
modification site information. ETD can be used to improve the sequence information in this case
because it is less sensitive to side-chain chemistry. It turns out that for studying oxidatively
modified peptides and proteins, ETD is a more valuable technique.

1.4 Bottom-up, Top-down and Middle-down for Protein Analysis
Bottom-up sequencing is the most commonly used method to sequence proteins by MS [77,
78]. In this approach, proteins of interest are digested into small peptides by a protease such as
trypsin or chymotrypsin, and then analyzed by LC/MS/MS. Figure 1.7 shows the general
protocol for the bottom-up sequencing of proteins. Proteolytic digestion, combined with
LC/MS/MS analysis, provides high sequence resolution.
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Figure 1.7 Schematic of bottom-up vs middle-down vs top-down approaches in proteomics.
The bottom-up approach is especially useful for identifying proteins and locating
modification sites on the protein since it provides peptide fragments that are readily solubilized,
separated and analyzed by MS. As shown in figure 1.3, after proteolytic digestion, different
peptides as well as same peptide with and without modification can be separated by HPLC.
Tandem MS followed by HPLC can easily locate the modification sites. Since this method
provides high sequence resolution, the labels can typically be localized to single amino acids.
This technique can also accurately determine the modification percentages for all the modified
sites, from which information such as reactivity of the amino acid can be easily drawn. Generally
bottom-up sequencing provides sufficient information to identify proteins and locate
modification sites. In some cases, however, only a small fraction of the peptide fragments are
detected, which is like having a jigsaw puzzle, where many of the pieces are missing. In this case,
then the modification information is also lost. Another disadvantage with this technique is it
usually takes a long time to do the digestion. One reason for the relatively long times of
conventional digestions is the low concentration of enzymes, like trypsin and chymotrypsin, that
17

are needed to avoid autolysis of the enzyme, which can complicate the observed mass spectra
due to strong background signal from ions originating from auto-digested enzyme. To solve this
problem, immobilized enzymes like trypsin and chymotrypsin have been developed. These
immobilized enzymes effectively have increased concentrations but are unable to cleave
themselves. Furthermore, the immobilized enzyme can be easily isolated and removed from the
protein digests prior to MS, eliminating or reducing the influence of the enzyme fragments on
MS results [79]. Immobilized enzymes allow achievement of complete digestion in minutes
rather than in hours when compared to solution-phase digests. This can greatly decrease the time
needed to do the labeling experiment.
An alternative to enzymatic digestion followed by MS/MS of the resulting peptides is
top-down sequencing[80-82], which involves MS/MS of the intact protein. Generally speaking,
the key advantage of the top-down approach is that the protein sequence and any modification
site(s) can be obtained potentially in a single MS/MS experiment. In addition, the long enzymatic
digestion step can be avoided to allow the analysis to be done more quickly. The main challenge
associated with top-down sequencing is the large number of product ions that result from protein
dissociation that can complicate spectral interpretation. Although the development of ECD and
ETD has made the top-down approach more feasible, expensive and difficult to maintain FT-ICR
and Orbitrap mass spectrometers are still the most effective tool because the mass resolving
power of ion traps is often insufficient to permit routine top-down studies. Another challenge for
top-down analysis of large proteins is the difficulty in obtaining fragments that cover the middle
region of the proteins because of the effect of the protein’s higher order structure on dissociation
[83]. Under this situation, the labeling information in the middle region of the protein is often
missing. Besides, in contrast to bottom-up sequencing, where modification percentage for all the
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modified sites can be accurately determined, top-down sequencing can hardly provide such
information. Furthermore, it is also difficult for top-down sequencing to localize the labels to
single amino acids.
Middle-down sequencing is an alternate approach for sequencing proteins and involves
direct MS/MS analysis of large protein fragments with limited proteolytic digestion. Middledown sequencing (as shown in figure 1.7), analyzes larger peptide fragments (>3 kDa) that are
produced from partial protein digestion. This approach combines some benefits of both bottomup and top-down sequencing [84]. Middle-down sequencing has been used by several
investigators and has been shown to be a higher-throughput sequencing approach [85], to provide
more complete sequence information[86], and to more effectively identify covalent modification
and post-translational modifications than bottom-up sequencing in some cases[87-89]. In the
middle-down experiment, a protein is first cleaved into a few large fragments, usually by limited
proteolysis, before being introduced into the HPLC and mass spectrometer for analysis. Because
middle-down sequencing provides large peptides, it is very possible that one peptide has multiple
modification sites. Typically HPLC can separate these isomers, and the modification sites can be
localized by tandem MS. Compared to a top-down experiment, middle-down experiments could
potentially increase the sequence resolution with only minimal additional sample preparation
[90], hence providing more detailed information about the location of labels. To do middle-down
experiments, enzyme such as Asp-N, Glu-C and Lys-C can be used to digest protein, and the
proteolytic processes can take between 20 min and 6 h[91-94]. In some cases, though, HPLC
cannot separate all modified peptide forms completely, making it difficult to accurately
determine the modification percentages.
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Bottom-up sequencing not only can locate the labels to single amino acids, but also can
provide reactivity information of the amino acids. This is also true for very large proteins since
the digestion process will cleave the protein to small peptide fragments. The major disadvantage
is some of the labeling information might be missing due to low sequence coverage for some
proteins. While top-down, on the other hand, potentially provides all the protein sequence and
any modification site(s) with very easy sample preparation. This technique, however, suffers the
disadvantage of relative expensive instrumentation, as well as missing labeling information in
the middle region of a large protein. The data analysis for top-down sequencing is also very
challenging. Middle-down sequencing lies between the above two techniques. Compared with
bottom-up, it can potentially provide more labeling information with larger peptides but may not
get reactivity information for all the modified amino acids. Compared with top-down sequencing,
it can provide more labeling information for larger proteins with minimal additional sample
preparation.

1.5 Summary
Covalent labeling combined with MS has seen increased interest in recent years because
it provides information about side chain solvent accessibility and is therefore particularly
valuable for studying protein-protein interfaces. The information obtained from this
methodology is complementary to other biophysical techniques. This dissertation presents
improvements in this approach so that it can provide more reliable information about protein
surface structure and protein-protein interactions.
In Chapter 2, we describe approaches for increasing protein structural resolution from
diethylpyrocarbonate-based covalent labeling and mass spectrometric detection. The
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improvements include using immobilized enzyme and Glu-C for short time digestion to increase
protein structural resolution.
Chapter 3 describes the rare phenomenon of label scrambling in solution and how to avoid
it. We demonstrate that free cysteine residues can capture carbethoxy labels from other modified
amino acid yet alkylation of these cysteines is a simple and effective way to avoid this
scrambling.
Chapter 4 describes a novel method for monitoring protein structural integrity using isotopically
encoded reagents.
In Chapter 5, the DEPC-based covalent labeling techniques are applied to monitor protein
structural changes during degradation processes.
Finally, Chapter 6 contains conclusions and future research directions.
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CHAPTER 2
INCREASED PROTEIN STRUCTURAL RESOLUTION FROM
DIETHYLPYROCARBONATE-BASED COVALENT LABELING AND MASS
SPECTROMETRIC DETECTION
This chapter is part of a paper published as: Zhou, Y.; Vachet, R. W. Increased Protein Structural
Resolution from Diethylpyrocarbonate-based Covalent Labeling and Mass Spectrometric
Detection. J. Am. Soc. Mass Spectrom. 2012, 23, 708-717.
2.1 Introduction
Mass spectrometry (MS) is playing an ever increasing role in the study of protein 3dimensional (3D) structure because more commonly used methods, such as NMR and X-ray
crystallography, have some limitations with regard to protein molecular size, conformational
flexibility, aggregation propensity, and/or limited sensitivity. Mass spectrometry alone cannot
provide direct information about protein 3D structure in solution, and therefore must be used
with labeling techniques such as H/D exchange [1-6], cross-linking [7-14], covalent labeling [1517],and non-covalent labeling [18-20]. Alternatively, ion mobilitymass spectrometry can also be
used to study protein structure in the gas phase [21-23]. Our group has been investigating
covalent labeling because such methods are complementary to H/D exchange and cross-linking,
and in some cases covalent labeling offers some advantages over these approaches. In
comparison to H/D exchange, for example, covalent labeling techniques provide structural
information about amino acid side chains, while having limited back-exchange and scrambling.
They also offer more straightforward data analysis as compared to cross-linking methods.
Covalent labeling approaches use reagents that non-specifically or specifically modify
solvent exposed amino acids, and these modified residues areidentified after proteolytic digestion
and tandem mass spectrometry (MS/MS). Differential reactivity of side chains can indicate
changes in protein structure, especially upon binding to a metal, ligand, or another protein [1531

17].Indeed, covalent labeling methods have significant merit when it comes to studying the
interfaces of protein-protein complexes because these methods probe the solvent accessibility of
amino acid side chains, which are critically important in mediating protein-protein interactions.
Numerous amino acid specific (e.g. succinimides for Lys residues) and non-specific (e.g.
hydroxyl radicals) reagents have been used for covalent labeling. We have recently demonstrated
that diethylpyrocarbonate (DEPC) has great promise as a labeling reagent for studying protein
structure [24-28]. Despite many studies using DEPC, even with MS-based detection [29-34],it
had been generally thought that this reagent reacts almost exclusively with His residues; however,
in recent studies we have shown that DEPC can react with Lys, Tyr, Cys, Ser, and Thr residues in
addition to His [24-27]. In fact, DEPC can potentially probe up to 30% of the residues in the
average protein. This degree of coverage could make DEPC a very general surface mapping
reagent for proteins having typical numbers of His, Tyr, Ser, Thr, Lys, and Cys residues. Because
reactions with DEPC also only produce one type of product, this reagent has nice advantages
when compared to non-specific reagents (e.g. hydroxyl radicals) that produce numerous product
types. In effect, sites modified by DEPC can be more readily and sensitively identified by MS
because modified peptide signals are not diluted across many products.
Although DEPC has great promise as a labeling reagent, we have found that DEPC does not
always efficiently label all solvent accessible His, Tyr, Ser, Thr, Lys, and Cys residues in a given
protein. One possible reason for this is that the reaction of DEPC with some amino acids is
reversible with half-lives depending on the modified amino acid. For example, Ncarbethoxyimidazole, which is the modified form of the histidine side chain, has a reported halflife of approximately 55 h at pH 7, 2 h at pH 2, and 18 min at pH 10 [35]. Lys and Tyr
modifications are thought to be irreversible and reversible, respectively [36], and modifications
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of Ser and Thr residues are reversible with half-lives that are probably under 20 h [24]. Reversal
of the covalent modification can lead to the loss of structural information especially if traditional
digestion procedures are used to generate peptide fragments for bottom-up sequencing. This
problem is especially critical for Ser and Thr residues because of their short half-lives and the
fact that Ser and Thr are the third and seventh most common amino acids in proteins [37],
accounting for about 13% of the sequence of an average protein. Methods that can reduce this
reversibility will be very helpful in obtaining more information from DEPC as a labeling reagent.
In this chapter, we have investigated the reversibility of several different DEPC-modified
amino acids in peptides and proteins and find that DEPC label loss occurs more readily than
previously thought. Using these data, we then show that the labeling (and thus structural)
information obtained with DEPC as a reagent can be substantially increased if the time between
the covalent labeling reaction and MS analysis is reduced. We find that short digestion times
minimize label reversibility and consequently enable the detection of twice as many modified
amino acids in some cases, thereby increasing protein structural resolution.

2.2 Experimental Procedure
2.2.1 Materials
Chymotrypsin was purchased from Roche Diagnostics (Indianapolis, IN) and immobilized
chymotrypsin and triethylamine acetate (pH 8.0) were from Princeton Separations (Adelphia,
NJ). Human β-2-microglobulin (β2m) was purchased from Fitzgerald Industries International,
Inc (Concord, MA). Diethylpyrocabonate (DEPC), imidazole, iodoacetamide, ammonium
bicarbonate,

sulfo-N-hydroxysuccinimide

acetate

(NHSA),

tris(2-carboxyethyl)phosphine

(TCEP), equine heart cytochrome c, equine skeletal muscle myoglobin and Glu-C were obtained
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from Sigma-Aldrich (St. Louis, MO). Ammonium acetate, methanol, acetonitrile, and acetic acid
were obtained from Fisher Scientific (Fair Lawn, NJ). Tris(hydroxymethyl)-aminomethane (Tris)
was purchased from EM Science (Gladstone, NJ). Centricon molecular weight cutoff (MWCO)
filters were from Millipore (Burlington, MA). Deionized water was generated from a Millipore
(Burlington, MA) Simplicity 185 water purification system. All the peptides used in this study,
except GH, GGH, and GGM were obtained from American Peptide Company (Sunnyvale, CA).
The peptides GH, GGH, and GGM were purchased from Sigma-Aldrich (St. Louis, MO).

2.2.2 Covalent modification
Carbethoxylation with DEPC: Stock solutions of DEPC were prepared in acetonitrile. The
DEPC reactions of peptides and proteins were performed for 1 min at 37 ºC and were initiated by
adding DEPC in a molar excess of 3 or 4. The total reaction volume for the experiments was 100
µL, and the total amount of acetonitrile added was 1%. The reactions were quenched after 1 min
by adding 10mM imidazole [24].
Acetylation with NHSA: Stock solutions of NHSA were prepared in water. The labeling of
peptides with 100 molar excess of NHSA was carried out for 3 min at 37 ºC. The reactions were
quenched by adding 200 mMTris.

2.2.3 Proteolytic digestion
Before proteolytic digestion, the modified proteins were cleanedwith a 10,000 MWCO filter
and reconstituted in deionized water to a final concentration of 250 µM. Cleaned β2m samples
were reacted with TCEP (protein:TCEP=1:40) to reduce the disulfide bond. Iodoacetamide was
added simultaneously at room temperature for 30 min in the dark to block the reduced
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Cysresidues. β2mand the other proteins were incubated with 10% (v/v) acetonitrileat 50 ºC for 45
min prior to digestion. Chymotrypsin was then added in a triethylamine buffer at pH 8.0 to yield
a final enzyme/substrate ratio of 1:20. For conventional overnight digestion, the samples were
incubated at 37 ºC for 16 h. For the microwave-assisted digestions, the protein/enzyme mixture
was irradiated in an MARS 230/6 microwave oven (CEM Corp., Matthews, NC) for 8 min. For
the ultrasound-assisted digestions, the protein/enzyme mixture was exposed to an ultrasonic field
for 4 h at 37 ºC using a Branson 3510R-MTH Ultrasonic Cleaner. The digestions were stopped
by inactivating the enzymes via the addition of acetic acid. For the 2 h digestions, immobilized
chymostrypsin was added to yield an enzyme/substrate ratio of 1:10, and the protein/enzyme
mixture was incubated at 37 ºC. After the digestion with the immobilized chymotrypsin, the
reaction mixture was centrifuged for 2 min at around 9000relative centrifugal force to separate
the enzyme from the protein. The enzyme Glu-C was used with an enzyme to protein ratio of
1:20 in an ammonium bicarbonate buffer at pH 8.0. The enzyme/protein mixture was incubated
at 25 ºC for 4 to 6 h. Acetic acid was then added to inactivate the enzyme and stop the digestion.
In all cases, the modified proteins were immediately analyzed after the digestions.

2.2.4 Instrumentation
All mass spectral measurements were carried out on a Bruker AmaZon (Billerica, MA)
quadrupole ion trap mass spectrometer equipped with an electrospray ionization source.
Typically, the needle voltage was kept at ~4 kV, and the capillary temperature was set to 250 ºC.
Either CID or ETD was used to generate tandem mass spectra. For the CID experiments, an
activation time of 40 ms was used, and the amplitude of the resonance excitation voltage during
the CID experiment was optimized to ensure efficient ion dissociation. In the ETD experiments,
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low m/z cutoff (LMCO) values ranging from 50 to 180 and reaction times ranging from 50 ms to
180 ms were used. When sequencing the peptides by CID or ETD, ions with abundances at least
10 times greater than the noise were considered as product ions.
HPLC-MS analyses were conducted using an HP1100 (Agilent, Wilmington, DE) with a
Discovery C18 column (15 cm × 2.1 mm, 5 µm particle size, Supelco, St. Louis, MO). Peptide
mixtures or peptide fragments from the proteolytic digests were eluted using a gradient of
methanol containing 0.1% acetic acid that increased from 10 to 100% methanol for 30 min at a
flow rate of 0.25 mL/min.

2.2.5 Determination of solvent accessibility surface area (SASA)
Protein SASA will initially be calculated from GETAREA [38] using the 3D structures of
proteins obtained from the Protein Data Bank (PDB). The PDB IDs for cytochrome c, myoglobin
and beta-2-microglobulin that were used to determine SASA were 1AKK, 1DWR and 1JNJ,
respectively.A probe radius of 1.4 Å, representing the van der waals sphere of water, will be used.
This probe radius has been most commonly used in other covalent labeling studies.

2.3 Results and Discussion
2.3.1 Reversibility of peptide and protein
To better understand the scope of the DEPC hydrolysis reaction, we investigated a series of
DEPC-modified peptides and proteins. Figure 2.1 shows an example of the modification
reversibility for the peptide pGlu-HPG after the peptide was modified by DEPC and allowed to
sit in solution for 10 min, 4 h, and 18 h at 37 ºC. The mass spectra in Figure 2.1 show that the
peaks corresponding to the modified peptide (m/z 493, [M+CEt+H]+ and m/z 515, [M+CEt+Na]+)

36

decrease in abundance the longer the peptide sits in solution. This observation indicates that the
modified His residue, which was confirmed by MS/MS, becomes unmodified over time.The
percent modification, which is equal to the sum of the ion abundances of [M+CEt+H]+ and
[M+CEt+Na]+ divided by the sum of the abundances of [M+CEt+H]+, [M+CEt+Na]+, [M+H]+,
and [M+Na]+, decreases from 77 ± 2 % at 10 min to 33.6 ± 0.5 % after 4 h to 0 % after 18 h.
Scheme 2.1 illustrates the hydrolysis reaction that labeled histidine undergoes [35]. It should be
noted that the DEPC-related product of the hydrolysis reaction, ethyl hydrogen carbonate, is
inherently unstable in water just like all the other alkyl hydrogen carbonates, and it readily
decomposes into carbon dioxide and ethanol [39]
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Figure 2.1Mass spectra of the DEPC-modified peptide pGlu-HPG after allowing the peptide to
sit in solution for (a) 10 min, (b) 4 h, and (c) 18 h after quenching the reaction with imidazole.
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Scheme 2.1 Hydrolysis of carbethoxylatedhistidine
Similar experiments were performed with a series of other peptides containing modified His,
Tyr, Lys, and N-termini (Table 2.1). For peptides with multiple modification sites, such as
RPKPQQFFGLM-NH2 and MEHFRWGK, LC was used to separate the isomers prior to MS
analysis. Two conclusions can be drawn from the data in Table 2.1. First, DEPC modifications to
Lys residues and the N-termini are not reversible during an 18 h period. Second, His and Tyr
residues more readily lose their label at rates that appear to depend on the surrounding amino
acid residues. The behavior of His and Tyr is similar to that noted in our previous work on Serand Thr-containing peptides [24]. Interestingly, despite a reported half-life of 55 h for modified
imidazoles at pH = 7 [35], we find that His residues in peptides can have much shorter half lives
in some cases.

Table 2.1 DEPC modification percentages for selected peptides after sitting in solution for
various time periods after reaction with DEPC. All the experiments were repeated three times,
and the means and standard deviations are reported.
Peptide sequence
pGlu-HPG
4
GHK
4
GH
4
KHG-NH2

Modification percentages2
10 min
4h
18 h
77 ± 2
33.6 ± 0.5
0.6 ± 0.93
68 ± 2
28 ± 6
1±1
72 ± 3
7±1
0.5 ± 0.6
53 ± 1
32 ± 3
11 ± 2

Modification
sites1
His
His
His
His
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4

GGH
pGlu-LYENK
Ac-YVKD-CHO
4
FYGPV
RPKPQQFFGLM-NH2

His
41 ± 1
18 ± 5
0.8 ± 0.2
Tyr
11.5 ± 0.8
4 ± 0.2
2.9 ± 0.2
Tyr
22 ± 1
16 ± 2
16.4 ± 0.8
Tyr
10 ± 2
4±2
1.6 ± 0.1
N-terminus
71 ± 3
67 ± 4
72 ± 3
Lys
2.9 ± 0.3
2.8 ± 0.1
2.9 ± 0.2
MEHFRWGK
N-terminus
22 ± 2
22 ± 1
23 ± 2
His
19 ± 1
13 ± 2
4±2
Lys
2±1
1.8 ± 0.3
2.0 ± 0.3
GGM
N-terminus
64 ± 4
65 ± 4
65 ± 2
1
Modification sites were confirmed by MS/MS.
2
Modification percentages are equal to the sum of the ion abundances of [M+CEt+H]+ and
[M+CEt+Na]+ divided by the sum of the abundances of [M+CEt+H]+, [M+CEt+Na]+, [M+H]+,
and [M+Na]+ (e.g. see Figure 2.1).
3
This modified peptide is not detected in every experiment.
4
Sulfo-N-hydroxysuccinimideacetate was used to block the N-termini and Lys side chains.
The modification reversibility of intact proteins was also investigated, and the results
indicate that modification losses for whole proteins are not as rapid as with smaller peptides. The
modification percentage for intact cytochrome c is 56 ± 3% when measured 10 minutes after the
modification is quenched; while its modification percentage is 57 ± 2% when measured after 24
hours (Figure 2.2). Similar experiments with myoglobin and β-2-microglobulin (β2m) indicate
modification percentages of 83 ± 2% (10 min) and 73 ± 5% (24 h) and 68 ± 3% (10 min) and 49
± 3% (24 h), respectively. One possible explanation for the lower modification loss from the
intact proteinsis that the protein buries the hydrophobic carbethoxy group in its interior after
modification, thereby slowing the hydrolysis reaction that results in the cleavage of this group.
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Figure 2.2 Expandedview of mass spectra showing the extent of DEPC modification for the +16
charge state of cytochrome c (a) 10 min after quenching the reaction and(b) 24 hrs after
quenching the reaction. CEt refers to the carbethoxy group that is added to the protein upon
reaction with DEPC. The modification percentage of the intact protein is determined from the
sum of the ion abundances for the modified protein divided by the total ion abundances for all
the peaks (modified and unmodified) for all the charge states. In (a) the modification percentage
is 56 ± 3% based on three separate experiments. In (b) the modification percentage is 57 ± 2%
based on three separate experiments.
2.3.2 The effect of digestion conditions on labeling information
Because label loss can be substantial for some residues during a standard enzymatic digest
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time period (e.g. 18 h), we investigated different digestion procedures to identify the conditions
that minimize label loss. Microwave [40, 41], ultrasonic irradiation [42-44]and immobilized
enzymes [45]are convenient ways to accelerate protein digestions, so each of these methods was
compared to conventional overnight digestion. For each digestion condition, the protein was first
labeled with DEPC under conditions known to minimize structural changes to the protein.
DEPC-protein reaction plotswere usedto ensure protein structural integrity during the labeling
reactions just as described in previous work [24]. Results show that each protein maintains its
structural integrity under the conditions used here.After enzymatically digesting the modified
proteins, both ETD and CID were used to sequence the peptide fragments and identify the
modification sites. Figure 2.3 gives two example tandem mass spectra to illustrate that
modification sites can be determined with single amino acid resolution.
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Figure 2.3 (a) Tandem mass spectrum acquired after CID of the [M+2H]2+ ion of the Gly37Tyr48 proteolytic fragment from cytochrome c. A series of unmodified y ions from y2 to y9, a
series of modified b ions from b4 to b12, a modified y10 ion, and an unmodified b2 ion confirm
that Lys39 is the site of modification. (b) Tandem mass spectrum acquired after ETD of the
[M+3H]3+ ion of the Ser11-Phe22 fragment of β2m. A series of modified c ions and a series of
unmodified z ions confirm that Ser11 is the site of modification. The product ions with an
asterisk are the product ions that contain the DEPC modification.
The DEPC modification sites and percentages obtained after digestion under different
conditions indicate that the 2 h digestion with immobilized chymotrypsin provides the most
labeling information (Table 2.2), both in terms of the number of modification sites found and the
modification percentages. Using β2m as an example, we find that the 2 h digestion is extremely
informative (Table 2.2). Given that residues with ≥ 30% solvent accessibility are usually
considered to be solvent exposed [38], the percentage of the surface exposed residues that can be
labeled (i.e. Ser, Thr, Lys, His, Cys, Tyr, and N-terminus, see Table 2.3) is 95% with the 2 h
digestion as compared to 76%, 38%, and 52% for the overnight, microwave-assisted, and
ultrasound-assisted digestions, respectively. In addition, the measured modification levels with
the 2 h digestion are higher in most cases. A similar trend is seen for cytochrome c (Table
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2.2).The same modification sites are observed under both overnight and the 2 h digestion
conditions, but fewer modification sites are observed after microwave and ultrasonic digestion
conditions, even though all of the digestion conditions provide > 90% sequence coverage. About
45% of the modifiable residues are found labeled with the overnight and 2 h digestions,
whereasonly 33% of the modifiable surface exposed residues are measured after the microwave
and ultrasound-assisted digestions. While the same number of modified sites is observed in
cytochrome c after overnight and 2 h digestions, the measured modification levels for some
amino acids are found to be higher in the 2 h digestion data (Table 2.2). The data for myoglobin
indicates that the 2 h digestion results in a slightly higher percentage of measured modified
residues (39%), whereas for the overnight (35%), microwave (29%), and ultrasound-assisted
(29%) digestions lower percentages of modified residues are measured (Table 2.2). Again, the
recovery of modifications is higher in almost all cases when the 2 h digestion is used.

Table 2.2 A comparison of the modification percentage under several different digestion
conditions for β-2-microglobulin, cytochrome c and myoglobin. All the experiments were repeated
three times, and the means and standard deviations are reported.
residue

H13
H31
H51
S11
S20
S28
S33
S55
S57/K58
Y10
Y67/T68
Y78
N-terminus
K6
K19

overnight

10 ± 3
0.1 ± 0.13
N.D.
10 ± 5
1.1 ± 0.5
0.6 ± 0.2
2.4 ± 0.8
2 ± 23
2 ± 23
N.D.
N.D.
N.D.
2.8 ± 0.4
0.20 ± 0.06
1.1 ± 0.3

2h

microwave

ultrasonic

β-2-microglobulin2
42.7 ± 0.7
14 ± 9
27.7 ± 0.3
4
7±1
N.D.
2 ± 23
10 ± 1
N.D.
N.D.
8±1
7±3
5±3
0.7 ± 0.1
0.8 ± 0.4
0.4 ± 0.3
0.31 ± 0.03
N.D.
N.D.
1.3 ± 0.3
N.D.
1 ± 13
3.4 ± 0.6
N.D.
N.D.
3.3 ± 0.6
N.D.
N.D.
0.065 ± 0.008
N.D.
N.D.
1.6 ± 0.8
N.D.
N.D.
0.7 ± 0.3
N.D.
N.D.
2.4 ± 0.4
3±2
2.3 ± 0.6
3
0.20 ± 0.07
0.2 ± 0.2
0.24 ± 0.05
4.1 ± 0.1
2±1
3±1
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2+24 h

% SASA
ratio1

10 ± 2
N.D.
0.7 ± 0.73
7±3
0.7 ± 0.3
N.D.
N.D.
N.D.
N.D.
N.D.
N.D.
N.D.
3.7 ± 0.7
N.D.
1.1 ± 0.2

50.8
32.7
54.7
11.4
65.0
19.7
66.4
55.9
35.2/96.3
41.9
22.5/2.5
6.0
85.0
80.1
69.0

K41
K48
K75
K91
K94
% labeled5

2.3 ± 0.5
13 ± 2
0.6 ± 0.1
1.5 ± 0.3
2.3 ± 0.4
76%

K25
K39
K53
K55
K60
K72
K73
K86
K87
K88
K99
K100
% labeled5

30 ± 5
17 ± 2
2.6 ± 0.2
6±1
1.6 ± 0.1
60 ± 3
18 ± 2
7±1
9.3 ± 0.6
1.6 ± 0.1
45 ± 3
24 ± 2
45%

H24
H36
H81
H116
S117
N-terminus
K16
K42
K45
K77
K78
K79
% labeled5

N.D.
1.9 ± 0.7
9±5
11 ± 7
0.6 ± 0.4
11 ± 1
1.8 ± 0.7
0.24 ± 0.08
0.24 ± 0.08
19 ± 6
36 ± 6
6±3
35%

1.

2.

3.
4.
5.

2.6 ± 0.7
8±2
0.4 ± 0.2
1.4 ± 0.3
2.1 ± 0.5
95%

N.D.
N.D.
N.D.
13 ± 1
N.D.
N.D.
1 ± 13
1.0 ± 0.3
2±1
1.4 ± 0.4
38%
52%
cytochrome C2
24 ± 2
13 ± 6
7±4
20 ± 3
18 ± 4
19 ± 5
4.6 ± 0.5
3±1
3.4 ± 0.9
9.1 ± 0.5
3 ± 33
7±3
1.60 ± 0.08
N.D.
N.D.
56 ± 3
N.D.
N.D.
27 ± 1
N.D.
N.D.
10 ± 1
7±2
8±1
9.5 ± 0.9
8±1
10.0 ± 0.3
1.7 ± 0.2
1.4 ± 0.2
1.77 ± 0.04
40 ± 10
30 ± 10
24 ± 2
22 ± 3
14 ± 6
14 ± 2
45%
33%
33%
2
Myoglobin
3.1 ± 0.4
N.D.
N.D.
6.4 ± 0.5
2.9 ± 0.9
1.0 ± 0.1
38 ± 1
18 ± 2
9±1
33.1 ± 0.7
N.D.
N.D.
1.74 ± 0.04
N.D.
N.D.
16 ± 3
19 ± 1
13 ± 2
1.3 ± 0.8
1 ± 23
2.3 ± 0.3
0.81 ± 0.06
0.4 ± 0.1
0.12 ± 0.02
0.81 ± 0.06
0.4 ± 0.1
0.12 ± 0.02
42 ± 8
45 ± 8
19 ± 3
37 ± 4
44 ± 6
27 ± 8
13 ± 2
14 ± 3
6±3
39%
29%
29%

1.9 ± 0.9
12 ± 2
N.D.
1.0 ± 0.2
1.5 ± 0.3
48%

14.1
81.8
92.3
61.5
67.8

23 ± 1
25 ± 3
1.1 ± 0.7
9.6 ± 0.7
N.D.
60 ± 10
17 ± 7
1 ± 13
8.1 ± 0.6
1.4 ± 0.1
14 ± 6
30 ± 10
41%

90.7
72.9
63.0
36.5
50.0
75.3
62.6
41.6
86.8
94.0
44.2
50.4

N.D.
3.2 ± 0.5
1 ± 13
N.D.
N.D.
39 ± 2
0.8 ± 0.83
0.40 ± 0.07
0.40 ± 0.07
3 ± 53
2 ± 23
1 ± 13
29%

2.7
32.6
89.1
43.9
51.3
97.8
22.1
33.0
54.9
50.5
46.2
53.6

SASA was calculated using GETAREA 1.1 [38]. 1.4 Å was used as the probe radius, and the
calculated SASA percentage is the ratio of the SASA of the side chain in the protein to the
SASA of the side chain (X) in the unstructured Gly-X-Glytripeptide. Residues with %SASA
values that exceed 50% are typically considered to be solvent exposed, and residues with
ratios less than 20% are typically considered to be buried. We chose 30% as the cutoff for
determining if a residue is solvent exposed.
The PDB IDs for β-2-microglobulin,cytochrome c and myoglobin that were used to
determine SASA were 1JNJ, 1AKK and 1DWR, respectively. For β-2-microglobulin, 1JNJ
consists of 20 NMR structures, and so the reported SASA values are the average from these
20 structures.
This modified peptide is not detected in every experiment.
N.D. indicates that modified peptide is not detected in any experiment under these
conditions.
% labeled corresponds to the percentage of the surface exposed modifiable (i.e. His, Lys,
Cys, Ser, Thr, and Tyr) residues that are found to be labeled. A complete list of modifiable
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residues in β-2-microglobulin,cytochrome c and myoglobin and their calculated SASA
values can be found in Table 2.3.

Table 2.3 Solvent accessible surface area (SASA) ratios for DEPC-modifiable amino acids in
cytochrome c, myoglobin and β-2-microglobulin. The modification status under two different
digestion conditions is indicated for cytochrome c and myoglobin.
Cytochrome c
residue
% SASA ratio
2h
Glu-C
1
His18
15.2
--His26
34.2
--His33
48.7
--Tyr48
25.9
--Tyr76
10.3
--Tyr74
27.3
--Tyr97
8.0
--Thr19
3.0
--Thr28
41.5
--Thr40
0.0
--Thr47
100.0
--Thr49
40.9
--Thr58
48.1
--Thr63
12.0
--Thr78
8.9
--Thr89
64.9
--Thr102
1.1
--N-terminus
53.9
--Lys5
78.8
-Labeled
Lys7
69.8
-Labeled
Lys8
75.4
-Labeled
Lys13
40.8
--Lys22
84.0
-Labeled
Lys25
90.7
Labeled
Labeled
Lys27
63.4
-Labeled
Lys39
72.9
Labeled
Labeled
Lys53
63.0
Labeled
Labeled
Lys55
36.5
Labeled
Labeled
Lys60
50.0
Labeled
Labeled
Lys72
75.3
Labeled
Labeled
Lys73
62.6
Labeled
Labeled
Lys79
68.3
-Labeled
Lys86
41.6
Labeled
Labeled
Lys87
86.8
Labeled
Labeled
Lys88
94.0
Labeled
Labeled
Lys99
44.2
Labeled
Labeled
46

Lys100
Cys172
% Labeled3
Myoglobin
residue
His24
His36
His48
His64
His81
His82
His93
His97
His113
His116
His119
Tyr103
Tyr146
Ser3
Ser58
Ser92
Ser108
Ser117
Thr34
Thr39
Thr51
Thr66
Thr70
Thr95
Thr132
N-terminus
Lys16
Lys42
Lys45
Lys47
Lys50
Lys56
Lys62
Lys63
Lys77
Lys78
Lys79
Lys87
Lys96
Lys98

50.4
44.6

Labeled
-45%

Labeled
-67%

% SASA ratio
2.7
32.6
64.7
26.6
89.1
4.9
35.3
43.3
43.2
43.9
20.0
15.2
4.2
63.8
9.1
0.0
5.4
51.3
33.9
1.9
61.8
40.2
71.8
76.2
45.8
97.8
22.1
33.0
54.9
0.0
83.4
58.3
48.0
75.3
50.5
46.2
53.6
52.0
84.2
65.0

2h
Labeled
Labeled
--Labeled
----Labeled
-------Labeled
-------Labeled
Labeled
Labeled
Labeled
-----Labeled
Labeled
Labeled
----

Glu-C
-Labeled
Labeled
Labeled
Labeled
--Labeled
Labeled
Labeled
-Labeled
Labeled
--Labeled
-Labeled
-----Labeled
-Labeled
-Labeled
Labeled
-Labeled
-Labeled
Labeled
Labeled
Labeled
Labeled
Labeled
Labeled
Labeled

47

Lys102
63.6
--Lys118
23.5
-Labeled
Lys133
44.8
--Lys145
16.4
-Labeled
Lys147
97.0
-Labeled
% Labeled3
39%
81%
β-2-microglobulin
residue
% SASA ratio
2h
His13
50.8
Labeled
His31
32.7
Labeled
His51
54.7
Labeled
His84
0.0
-Tyr10
41.9
Labeled
Tyr26
25.8
-Tyr63
27.1
-Tyr66
7.0
-Tyr67/Thr68
22.5/2.5
Labeled
Tyr78
6.0
Labeled
Ser11
11.4
Labeled
Ser20
65.0
Labeled
Ser28
19.7
Labeled
Ser33
66.4
Labeled
Ser52
43.8
-Ser55
55.9
Labeled
Ser57/Lys58
35.2/96.3
Labeled
Ser61
27.1
-Ser88
90.1
-Thr4
83.8
-Thr71
36.0
-Thr73
61.4
-Thr86
17.8
-N-terminus
85.0
Labeled
Lys6
80.1
Labeled
Lys19
69.0
Labeled
Lys41
14.1
Labeled
Lys48
81.8
Labeled
Lys75
92.3
Labeled
Lys91
61.5
Labeled
Lys94
67.8
Labeled
Cys25
0.0
-Cys80
0.0
-3
% Labeled
95%
1. -- indicates that modified peptide is not detected.
2. GETAREA ignores the heme in cytochrome c, so it calculates Cys17 to be solvent
exposed when it is really not because it is covalently bound to the heme.
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3. % labeled corresponds to the percentage of the surface exposed modifiable (i.e. His, Lys,
Cys, Ser, Thr, and Tyr) residues that are found to be labeled.
The relatively low recovery of modified amino acids after microwave and ultrasoundassisted digestions is interesting. The results suggest that in addition to accelerating the digestion
reactions, microwaves and ultrasound also accelerate hydrolysis of the DEPC-modified residues,
even to greater extents than they accelerate proteolysis, thereby increasing the modification
losses. Several papers report that microwave irradiation can accelerate common organic
transformations such as hydrolysis reactions [46, 47]. Moreover, microwaves also accelerate the
hydrolysis of peptide bonds in the absence of enzymes [48, 49]. Ultrasonic irradiation is also
known to accelerate hydrolysis reactions [50].Therefore, it appears that microwave- and
ultrasound-assisted digestion methods are not good choices when trying to identify residues
modified by DEPC.
To confirm that the shortened digestion timesenable more modifications to be retained
before MS analysis, labeled proteins were digested for 2 h with immobilized chymotrypsin, and
then, after removing the immobilized chymotrypsin, the resulting peptide fragments were
incubated at 37 ºC for 24 h to monitor if further label loss occurred (Table 2.2,6thcolumn). The
data clearly indicate that label loss occurs as a result of the peptide fragments remaining in
solution for an additional 24 h. These observations confirm that label loss occurs over time and
that shorter digestion times help minimize label loss, so that a greater number and percentage of
modified residues can be retained and measured. The extents of label loss follow the trends
observed in Table 2.1 and in our previous work [24].The modification percentages for the Ntermini and Lys residues do not substantially decrease after 24 h, indicating that they maintain
their labels. In contrast, His, Tyr, Ser, and Thr residues more readily lose their labels after sitting
in solution for 24 h. These experiments also help us understand the label loss data for the
49

undigested proteins described above.Cytochrome c did not lose any DEPC modifications (56 ±
3% to 57 ± 2%) after sitting in solution for 24 h, while β2mlost more labels (68 ± 3% to 49 ± 3%)
after sitting in solution for 24 h. Almost all of the residues labeled in cytochrome c areLys
residues, which undergo little label loss. For β2m, more than half of the modification sites are
His, Tyr, Ser, or Thr residues, which are the amino acids that most easily lose the modification.
It is important to note, however, that the amount of label loss observed for the intact
β2mafter 24 h is not as great as expected based on the 2+24 h results in Table 2.2. Less label
lossin the case of the undigested protein suggests that intact modified proteins might partially
bury the DEPC modified side chains, thereby slowing hydrolysis. If this is the case, then we
might be able to increase modification recoveries by generating larger proteolytic fragments that
partially protect the modified residues from hydrolysis.

2.3.3 Glu-C and middle-down sequencing
To test the idea that longer peptide fragments may protect the modified residues from
hydrolysis, we used the enzyme Glu-C to generate longer proteolytic fragments, while still
maintaining a short overall digestion time. Glu-C cleaves peptide bonds on the C-terminal side of
Glu residues. The fragments that are typically produced are large enough that this could be
considered a form of middle-down sequencing [51-55].The larger peptide fragments produced by
Glu-C lead to more peptide fragments with multiple modification sites. In many cases, LC is able
to separate these peptide isomers, so that MS/MS can readily confirm the modification sites. For
example, the peptide fragment,

106

FISDAIIHVLHSKHPGDFGADAQGAMTKALE136, from

myoglobin was found to be modified at H113, H116, S117, and K118. Each of these modified
forms of the peptide can be separated by LC, and the modification sites can be determined by
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ETD (Figure 2.4). In other cases, modified peptide isomers elute at the same time, but ETD of
these isomers almost always enables the multiple modification sites to be unambiguously
identified. For example, the peptide fragment,

137

LFRNDIAAKYKE148, from myoglobin was

found to be modified at K145 and K147 even though these modified forms elute together (Figure
2.5). Unfortunately, the inability to completely separate all modified peptide forms makes it
difficult to accurately determine the modification percentages for all the modified sites.

Figure 2.4 (a) Extracted ion chromatogram (EIC) of m/z 671, which is the +5 ion of the DEPCmodified peptide 106FISDAIIHVLHSKHPGDFGADAQGAMTKALE136 from myoglobin. (b)
An example ETD tandem mass spectrum of the first chromatographic peak of the modified
Phe106-Glu136 fragment, illustrating how ETD can identify the modified amino acid. A series
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of unmodified z ions from z2 to z19, modified z20, z22, and z27 ions, a series of unmodified c ions
from c2 to c11, and a series of modified c ions from c12 to c27confirm that Ser117 is the site of
modification. The product ions with an asterisk are the product ions that contain the DEPC
modification.

Figure 2.5 (a) Extracted ion chromatograms (EIC) of m/z 514 (red) and 385.7 (black), which are
the +3 and +4 charge state of the DEPC-modified peptide 137LFRNDIAAKYKE148 from
myoglobin. (b) An example ETD tandem mass spectrum of the second chromatographic peak of
the modified Leu137-Glu148 fragment, illustrating how ETD can identify two modified sites. A
series of unmodified c2 to c8 ions, a mix of modified and unmodified c9 and c10 ions, and a
modified c11 ion indicate that both K145 and K147 are modified. Note: modified z2 and z3 ions
are not observed because when K147 is modified these products are no longer charged.
Because only 45% and 39% of the modifiable surface exposed residues of cytochrome c and
myoglobin are labeled using the 2 h digestion procedure, we only digested these proteins with
Glu-C. 95% of the modifiable residues in β2m are already labeled, so middle-down sequencing is
not expected to provide significantly more information for this protein. In addition, the relatively
high number of Glu residues in β2m yields peptide fragments that are similar in size to those
52

generated by chymotrypsin, thereby providing no real advantage. In contrast, Glu-C generates
peptide fragments for cytochrome c and myoglobin that have, on average, almost twice as many
residues as those produced by chymotrypsin.
When Glu-C is used to digest DEPC-modified cytochrome c and myoglobin, we found six
new modification sites for cytochrome c and 17 new sites for myoglobin as compared to the 2 h
digestion with chymotrypsin. The six new sites that are modified in cytochrome c are all Lys
residues. Overall, the measured modification sites in this protein upon Glu-C digestion are: Lys5,
Lys7, Lys8, Lys22, Lys25, Lys27, Lys39, Lys53, Lys55, Lys60, Lys72, Lys73, Lys79, Lys86,
Lys87, Lys88, Lys99, and Lys100 (Table 2.3). The presence of newly found modified Lys
residues suggests that some Lys residues can undergo hydrolysis at faster rates in some
circumstances even though the data in Tables 2.1 and 2.2 indicate the label loss reaction is slow
for Lys. The inability to find additional modified His, Thr, Ser, or Tyr residues might be because
there are only 7 of these residues that have SASA percentages above 30% and most of them have
SASA percentages close to 30%. Overall, a total of 18 residues were found to be modified,
which corresponds to 67% of the modifiable residues in cytochrome c (see Table 2.3 for a
complete list of modifiable residues and their modification status). This is a clear improvement
over the 45% obtained with the 2 h digestion with chymotrypsin.
For myoglobin, a total of 27 modification sites were found. These sites are: the N-terminus,
His36, His48, His64, His81, His97, His113, His116, Tyr103, Tyr146, Ser92, Ser117, Thr95,
Lys42, Lys45, Lys50, Lys62, Lys63, Lys77, Lys78, Lys79, Lys87, Lys96, Lys98, Lys118, Lys145,
and Lys147 (Table 2.3). As indicated before, 17 of these sites are new. Eight of these new sites
are His, Tyr, Ser, or Thr residues. Two of these newly identified sites, Tyr146 and Ser92, have
low SASA percentages (Table 2.3). Even though the modification percentages for these residues
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are very low (i.e. < 1 %), observing these sites modified might suggest that a small fraction of
the proteins are structurally perturbed, thereby exposing these residues. Our previous DEPC
labeling experiments with myoglobin gave no evidence for any perturbations to the protein
structure under identical reaction conditions [24], but the ability to find more modified sites with
the current conditions could be revealing that some fraction of the proteins do undergo slight
structural perturbations. This possibility highlights the advantage of being able to identify more
labeled sites. The remaining nine newly discovered sites in myoglobin are Lys residues.
Considering these data as a whole, we find that 81% of the solvent exposed modifiable residues
are labeled when the protein is analyzed using Glu-C and middle-down sequencing (see Table
2.3 for a complete list of modifiable residues and their modification status). This percentage of
measured modification sites is a significant improvement over the 39% that was obtained with
the 2 h digestion using chymotrypsin.
Increasing the number of measured modification sites is advantageous for protein structure
determination. In effect, measuring more modified residues provides greater protein structural
resolution. To quantify the improved resolution obtained with the shorter digestion conditions,
we calculated the average distance between adjacent modification sites to arrive at an effective
resolution for each digestion condition. To do this, we mapped the measured modification sites
on the crystal or NMR structure of each protein (e.g. Figure 2.6), and then the distance between a
given modified residue and the next closest modified residue was determined using Pymol [56].
The overall average of these distances was then calculated to provide an effective resolution.
Figure 2.6 illustrates the measured modification sites mapped on the crystal structure of
myoglobin using the data from two different digestion conditions. This figure shows that a
greater effective resolution is obtained upon digesting the protein with Glu-C (Figure 2.6b) as
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compared to a conventional overnight digestion (Figure 2.6a). The protein structural resolution
that is calculated upon the Glu-C digestion is 7 ± 2 Å, while the resolution from the overnight
digestion data is 11 ± 3Å. Conducting a similar calculation for all three proteins under the
different digestion conditions indicates that in all cases the structural resolution is greater when a
shorter digestion time is used (Table 2.4).

Figure 2.6 Mapping of the measured modification sites on myoglobin. (a) Modification sites
after conventional overnight digestion and (b) modification sites after digestion with Glu-C. The
DEPC modified residues are indicated in red.
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Table 2.4 Calculated protein structural resolution from DEPC-based labeling after digesting the
proteins under different conditions.
β-2-microglobulin
myoglobin
cytochrome c
Glu-C
7 ± 21
10 ± 3
-2h
10 ± 3
13 ± 5
8±3
overnight
11 ± 3
13 ± 5
9±3
microwave 11 ± 3
14 ± 5
11 ± 5
ultrasonic
11 ± 3
14 ± 5
9±3
2+24 h
11 ± 3
13 ± 5
11 ± 5
1
The resolution was calculated by considering the average distance between adjacent
modification sites after mapping the measured modification sites on the crystal or NMR structure
of each protein.
2.4 Conclusions
By studying several peptides and proteins, we find that DEPC-modified amino acids are
more labile than previously thought. This lability can lead to losses in protein structural
information. Label loss is most significant for Ser, Thr, and Tyr residues but also occurs readily
for His residues. By shortening the time between the modification reaction and MS analysis,
though, the number of modification sites that are identified after labeling with DEPC can be
increased, and this greater number of labeled sites translates into increased structural information.
As expected, more extensive levels of DEPC modification are primarily due to limiting the
hydrolysis of Ser, Thr, Tyr, and His residues. The decreased time between the modification
reaction and protein sequencing analysis by MS can be achieved using shorter digestion times.
Microwave and ultrasonic-irradiation are two ways to accelerate protein digestion, but these
methods also accelerate hydrolysis to a greater extent, resulting in lower measured levels of
modification. In contrast, a simple two-hour digestion with immobilized chymotrypsin was
found to be superior for obtaining more structural information for the proteins studied here.
Surprisingly, protein digestion using Glu-C coupled with middle-down sequencing provides the
most extensive labeling information. Indeed, the number of labeled sites increases by 1.5-fold for
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cytochrome c and 2-fold for myoglobin, resulting in notable improvements in the structural
resolution of this covalent labeling technique. This phenomenon is likely due to the production
of larger peptide fragments that are able to partially bury the relatively hydrophobic carbethoxy
group, thereby shielding the modified residues from hydrolysis. Overall, the amount of structural
information that is accessible with DEPC indicates that it might be useful as a standalone
labeling reagent when followed by short digestion times and middle-down sequencing, although
alternate short-time digestion conditions would need to be optimized for more intractable
proteins. Because this reagent also only produces a single reaction product, thereby simplifying
the MS analysis, it may serve as a viable alternative to hydroxyl radical labeling.
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CHAPTER 3
DIETHYLPYROCARBONATE LABELING FOR THE STRUCTURAL ANALYSIS
OF PROTEINS: LABEL SCRAMBLING IN SOLUTION AND HOW TO AVOID IT
This chapter is part of a paper published as: Zhou, Y.; Vachet, R. W. Diethylpyrocarbonate
Labeling for the Structural Analysis of Proteins: Label Scrambling in Solution and How to Avoid
it. J. Am. Soc. Mass Spectrom. 2012, 23, 899-907.

3.1 Introduction
Mass spectrometry (MS) is increasingly being used as a means of studying the higher
order structure of proteins and protein complexes. While other methods, such as NMR and X-ray
crystallography, provide more detailed structural information, there are some limitations to these
methods. For example, some proteins are difficult to study by these methods due to size,
conformational flexibility, aggregation propensity, or limited sample amount. As such, MS
combined with labeling techniques has been investigated to address some of these shortcomings.
H/D exchange [1-6], chemical cross-linking [7-13], covalent labeling [14-23], and non-covalent
labeling [24-26] are commonly used techniques. Each of these approaches results in the
modification of multiple amino acids, and except for the non-covalent labeling approach protein
structural information is obtained by identifying the protein sites that are modified by MS and/or
MS/MS after proteolytic digestion. H/D exchange uses deuterium as a reagent to measure
backbone amide hydrogen exchange rates. These rates are then used to provide information
concerning protein structure, dynamics, and interactions. When combined with MS, H/D
exchange is a very powerful tool because it gives information about virtually every backbone
amide; however, it does not provide information about amino acid side chain positions and also
suffers from back-exchange and scrambling if special care is not taken during the MS
measurements. In chemical cross-linking experiments new intra- or inter-molecular bonds are
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created that set distance constraints on the location of two amino acid side chains. The resulting
set of distance constraints can then be used to deduce protein structure, especially for proteinprotein and protein-ligand complexes. One challenge with cross-linking experiments is the
identification and sequencing of the resulting cross-linked peptides.
Mass spectrometry has also being used in combination with covalent labeling reactions to
study protein structure [21]. In comparison to H/D exchange, covalent labeling does not suffer
much from label back-exchange or scrambling, and it also provides structural information about
amino acid side chains, making it complementary to H/D exchange. Covalent labeling also has
some similarities to chemical cross-linking in that it covalently modifies amino acid side chains.
In covalent labeling experiments, however, only a single polypeptide chain is modified, making
mass spectral and data analyses more straightforward. There are two general types of covalent
labeling reagents – those that modify many different amino acids (e.g. hydroxyl radicals [14-20,
23, 27]) and those that react with specific amino acids (e.g. succinimides that react with lysine
residues [21, 28, 29]). Hydroxyl radicals are commonly used and irreversibly modify proteins
and other macromolecules. Amino acid specific labels also typically irreversibly modify amino
acid side chains. Although, there are a few examples of labels, such as arginine-specific
dicarbonyl compounds that label reversibly and therefore require additional reagents to stabilize
them [21].
Our group has been investigating diethylpyrocarbonate (DEPC) as a multi-residue
labeling reagent because we have found that it can probe up to 30% of the residues in the average
protein, including the N-terminus, His, Lys, Tyr, Ser, Thr and Cys residues [22]. DEPC also
generates only one product type, carbethoxylated residues, allowing for straightforward and
sensitive analyses of the modified amino acids. We and others have shown that DEPC labeling
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can provide useful structural information for proteins and protein-protein interactions [22, 30-35].
Due to DEPC’s molecular size, proteins are typically only labeled at amino acids that are
exposed to solvent on the protein surface. Amino acids that are buried inside the protein are
usually not labeled. Thus, DEPC is particularly useful for studying protein-protein complexes.
In the course of our work with DEPC, we have noticed for some proteins that Cys
residues that form disulfide bonds can be modified by DEPC. The thiol groups of free Cys
residues are known to bevery reactive with electrophilic compounds, but the disulfide formed by
two Cys residues is typically much less reactive toward electrophiles. In the present work, we set
out to understand this observed reactivity in order to establish whether or not disulfides indeed
react with DEPC or whether something else explains the modification of disulfide bonded Cys
residues. From a series of labeling experiments with proteins and Cys-containing peptides, we
have discovered that unmodified free Cys residues can capture a carbethoxy group from other
DEPC modified amino acids via a solution phase reaction. This “scrambling” of covalently
modified residues is very atypical for covalent labeling/MS experiments and would seem to
lessen the utility of DEPC as a labeling reagent. Fortunately, though, addition of an alkylating
agent (e.g. iodoacetamide) during protein digestion prevents this scrambling and ensures the
fidelity of the information obtained from the DEPC labeling experiments.

3.2 Experimental Procedure
3.2.1 Materials
Human β-2-microglobulin (β2m) was obtained from Fitzgerald Industries International,
Inc (Concord, MA). Immobilized chymotrypsin and triethylamine acetate (pH 8.0) were obtained
from Princeton Separations (Adelphia, NJ). Diethylpyrocarbonate (DEPC), imidazole,
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iodoacetamide, and tris(2-carboxyethyl)phosphine (TCEP) were purchased from Sigma-Aldrich
(St. Louis, MO). Ammonium acetate, methanol, acetonitrile, and acetic acid were purchased
from Fisher Scientific (Fair Lawn, NJ). Centricon molecular weight cutoff (MWCO) filters were
obtained from Millipore (Burlington, MA). Deionized water was generated with a Millipore
(Burlington,

MA)

(SLRRSSCFGGR),

Simplicity

185

Angiotensin

water
I

purification

system.

(DRVYIHPFHL),

The
and

peptides

ANP

semastatin

(SPWTKCSATCGGGHYMRTR) were from American Peptide Company (Sunnyvale, CA).

3.2.2 DEPC modification
The modification reactions of peptides and proteins were performed for 1 min at 37 ºC
and were initiated by adding DEPC in acetonitrile in a molar excess of 4. The total amount of
acetonitrile added was 1 µL and the total reaction volume was 100 µL. After 1 min, 10 mM
imidazole was added to quench the reaction [22].

3.2.3 Proteolytic digestion
Before the addition of enzyme, DEPC-reacted β2m was purified using a 10,000 MWCO
filter to reduce the concentration of the reagent used to quench the DEPC reaction (see DEPC
modification procedure below). Before filtering, the volume of the β2m sample was 100 µL. The
volume was then reduced to approximately 10 µL during the filtering step, and then the sample
was reconstituted with deionized water to a volume of about 40 µL, resulting in a β2m
concentration of about 250 µM. β2m was then incubated in a buffer solution (100 mM
triethylamine at pH 8.0) with 10% (v/v) acetonitrileat 50 ºC for 45 min prior to digestion. β2m
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samples were then reacted with TCEP (protein:TCEP=1:40 molar ratio) to reduce the disulfide
bond, while for proteins in which the disulfide bond was not reduced, TCEP was not added. In
some cases, iodoacetamide was also added (~80 fold molar excess over the protein) at the same
time as TCEP to alkylate the free Cys residues. Under these reaction conditions, the cysteine
residues were 100% alkylated as determined by LC/MS analysis. Stock solutions of
iodoacetamide were prepared in triethylamine acetate at pH 8.0, and alkylation reactions were
carried out in the dark for 30 min. Immobilized chymostrypsin was added to yield an
enzyme/substrate ratio of 1:10, and the protein/enzyme mixture was incubated at 37 ºC. After 2 h
of digestion, the enzyme was separated from the protein by centrifuging the reaction mixture for
2 min at 1000 RPM. In all cases, the modified proteins were analyzed right after digestion.

3.2.4 Instrumentation
Mass spectra were acquired on a Bruker AmaZon (Billerica, MA) quadrupole ion trap
mass spectrometer equipped with an electrospray ionization source. Typically, the electrospray
needle voltage was kept at ~4 kV, and the capillary temperature was set to 250 ºC. Either CID or
ETD was used to obtain tandem mass spectra. In the CID experiments, an activation time of 40
ms was chosen, and the amplitude of the resonance excitation voltage was optimized to ensure
efficient ion dissociation. For the ETD experiments, fluoranthene radical anions, which were
generated via negative chemical ionization with methane reagent gas, were used with an
accumulation time of 10 ms. The ETD parameters that were used are the following: low m/z
cutoff (LMCO) values ranging from 50 to 180, reaction times ranging from 50 ms to 180 ms.
The values were chosen to give the most efficient dissociation. For direct injection experiments,
samples were delivered at 2 µl/min with a syringe pump. An HP1100 HPLC system (Agilent,
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Wilmington, DE) with a Discovery C18 column (15 cm × 2.1 mm, 5 µm particle size, Supelco, St.
Louis, MO) was used for HPLC analysis. Peptide mixtures or peptide fragments from the
proteolytic digests were eluted using a linear gradient of methanol increased from 10 to 100%
methanol for 30 min. The mobile phase contained 0.1% acetic acid and had a flow rate of 0.25
mL/min.

3.3 Results and Discussion
3.3.1 Modification of cysteines in a buried disulfide bond
Upon DEPC labeling of the protein β2m, 70% (19/27) of the modifiable solvent exposed
amino acids are modified (Figure 3.1 and Table 3.1, column 5), which is consistent with previous
work [22, 36]. Residues with ≥ 30% solvent accessibility are typically considered to be solvent
exposed, and residues with 10-30% solvent accessibility are usually recognized as partially
exposed [37]. The DEPC reaction appears to be fairly selective for labeling solvent exposed
residues as only 4 partially exposed residues and 3 “buried” residues are labeled by DEPC. The
modification percentages for partially exposed residues, such as Ser11, Ser28, Lys41 and
Tyr67/Thr68 are relatively low, ranging from ~0.3 to 4%, which is consistent with these residues
being only partially exposed. The buried residues that are modified are Cys25, Cys80, and Tyr78.
The modification percentage for Tyr78 is very low, only ~0.1%. This low level of modification
may reflect protein dynamics that partially expose this residue to solvent. Indeed, in the NMR
structures used to determine solvent accessibilities for β2m, a few of the structures have this
residue partially exposed [38]. The relatively high modification percentages for Cys25 and
Cys80 (Figure 3.1, red bars), however, are surprising. The residues are not only completely
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buried in all the NMR structures, but they also form a disulfide bond. As such, they should not
react with DEPC at all. Nonetheless, after reacting the protein as described in the experimental
section and then reducing and digesting the protein, we find two peptides,
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23

LNCY26 and

ACRVNHVTL87, that contain DEPC-modified cysteine residues (Figure 3.2). In addition, these

two Cys residues are modified to significant extents.
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Figure 3.1 DEPC modification percentages for residues in β-2-microglobulin under different
conditions as explained in the text and experimental section. All experiments were repeated three
times, and the means and standard deviations are reported. Table 3.1 provides a list of the solvent
accessible surface areas for each of these labeled residues and the numerical modification
percentages for each residue. TCEP corresponds to tris(2-carboxyethyl)phosphine, and IAM
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corresponds to iodoacetamide.
Table 3.1 Solvent accessible surface area (SASA) for DEPC-modifiable amino acids and the
modification percentages of DEPC-modified β-2-microglobulin under different conditions. All
the experiments were repeated three times, and the means and standard deviations are reported.
residues

C25
C80
N-terminus
K6
K19
K41
K48
K75
K91
K94
H13
H31
H51
S11
S20
S28
S33
S52
S55
S57/K58
S61
S88
Y10
Y26
Y63
Y67/T68
Y78
T4
T71
T73

% SASA ratioa
average
0.1±0.1
0.02±0.06
80±10
80±3
69±7
14±4
80±12
90±10
62±9
70±10
51±9
30±11
55±6
10±12
70±11
20±3
66±4
44±9
56±5
35±9/96±5
27±9
90±10
42±9
26±3
27±4
22±3/2±2
6±2
84±5
36±6
61±6

max
0.5
0.2
98.0
85.4
81.2
23.5
100
100
74.8
87.6
66.8
49.3
61.9
44.1
90.9
27.3
70.8
70.5
66.5
52.5/100
49.8
100
54.0
32.3
36.5
27.3/5.2
10.8
92.1
50.0
74.2

TCEP
min
0
0
63.0
75.4
59.4
7.6
63.6
72.0
43.1
49.2
38.6
10.2
40.3
0.0
42.5
10.9
53.5
24.6
46.1
19.3/84.4
14.8
74.4
24.9
20.9
17.9
15.3/0.0
3.5
75.8
28.2
49.6

2h
52 ± 2
15 ± 5
2.94 ± 0.07
0.3 ± 0.1
3.4 ± 0.4
2.1 ± 0.9
6.8 ± 0.8
0.31 ± 0.03
2.0 ± 0.5
2.9 ± 0.7
35 ± 5
3.3 ± 0.6
10.2 ± 0.1
4±1
0.36 ± 0.09
0.27 ± 0.04
1.21 ± 0.09
N.D.
2±1
3±1
N.D.
N.D.
0.13 ± 0.06
N.D.
N.D.
0.57 ± 0.02
0.10 ± 0.02
N.D.
N.D.
N.D.

a

2 + 24 h
91 ± 7
100 ± 0
3±1
0.4 ± 0.2
1.0 ± 0.2
2.8 ± 0.8
15 ± 4
0.4 ± 0.1
1.75 ± 0.03
2.62 ± 0.05
9±1
0.7 ± 0.2
N.D.
4 ± 4c
0.5 ± 0.5c
0.5 ± 0.2
1.1 ± 0.5
N.D.
2.8 ± 0.4
5±2
N.D.
N.D.
N.D.
N.D.
N.D.
0.5 ± 0.1
0.1 ± 0.1 c
N.D.
N.D.
N.D.

without
TCEP
2h
N.D.b
N.D.
2.6 ± 0.8
0.21 ± 0.03
3.6 ± 0.5
2.0 ± 0.5
5±1
0.2 ± 0.2c
1.4 ± 0.3
2.0 ± 0.5
41 ± 7
3.8 ± 0.7
6±1
13.3 ± 0.4
1.24 ± 0.03
0.30 ± 0.07
2.4 ± 0.8
N.D.
5±2
3±2
N.D.
N.D.
0.07 ± 0.03
N.D.
N.D.
2±1
1.8 ± 0.9
N.D.
N.D.
N.D.

TCEP/iodoac
-etamide
2h
N.D.
N.D.
2.4 ± 0.4
0.20 ± 0.07
4.1 ± 0.1
2.6 ± 0.7
8±2
0.4 ± 0.2
1.4 ± 0.3
2.1 ± 0.5
42.7 ± 0.7
7±1
10 ± 1
8±1
0.7 ± 0.1
0.31 ± 0.03
1.3 ± 0.3
N.D.
3.4 ± 0.6
3.3 ± 0.6
N.D.
N.D.
0.065 ± 0.008
N.D.
N.D.
1.6 ± 0.8
0.7 ± 0.3
N.D.
N.D.
N.D.

The PDB ID for β-2-microglobulin that was used to determine SASA was 1JNJ. This PDB ID
corresponds to a collection of 20 protein conformers obtained from NMR measurements. SASA
values were calculated using GETAREA 1.1 [37]. The average SASA values, as well as the
maximum and minimum values, are reported. 1.4 Å was used as the probe radius. GETAREA
calculates SASA percentages as the ratio of the SASA of the side chain in the protein to the
SASA of the side chain (X) in the hypothetical unstructured Gly-X-Glytripeptide.
b
N.D. indicates that modified peptide is not detected in any experiment under these conditions.
c
This modified peptide is not detected in every experiment.
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Figure 3.2 (a) Tandem mass spectrum acquired after CID of the [M+H]+ ion of the Leu23-Tyr26
proteolytic fragment of β2m. Unmodified b2, y1 and modified b3, y2, y3 ions confirm that Cys25
is the site of modification. (b) Tandem mass spectrum acquired after ETD of the [M+3H]3+ ion of
the Ala79-Leu87 fragment of β2m. A series of modified c2 to c8 ions and a series unmodified z3
to z7 with modified z8 confirm that Cys80 is the site of modification. The product ions with an
asterisk are the product ions that contain the DEPC modification.

One possible explanation for the modification of Cys25 and Cys80 is that DEPC is not
fully removed during the quenching step with imidazole such that this reagent can react with the
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free cysteine groups that are made available during the reduction and digestion steps. To test
whether there is still DEPC left in the sample, the peptide angiotensin I (DRVYIHPFHL) was
added into the sample after the quenching and filtering steps. If DEPC remained in the solution,
we would expect this peptide to be modified by DEPC at one or more of its His residues, but no
modification of angiotensin I is observed (data not shown), indicating that the DEPC is fully
quenched by imidazole.
Another possible explanation for the modification of Cys25 and Cys80 is that the free
thiols of these residues are able to capture a carbethoxy group from another modified amino acid
via an intra- or intermolecular reaction (Scheme 1) after the disulfide bond is reduced. Several
experiments were carried out to test this hypothesis.First, the modified protein was enzymatically
digested without adding TCEP to reduce the disulfide bond. LC/MS experiments reveal the
presence of the disulfide-linked peptide,

23

LNCY26/79ACRVNHVTL87, without any measurable

modification. This result indicates that the disulfide linked Cys residues do not react with DEPC
in the intact protein or in peptide fragments. Moreover, the modification levels for many of the
other residues, especially His, Ser, and Tyr residues, are found to increase (Figure 3.1, compare
red and green bars and Table 3.1, compare columns 5 and 7), which is consistent with the idea
that Cys can no longer capture the carbethoxy group from these other residues. In a second set of
experiments, the modified protein with all residual DEPC completely removed (as confirmed by
the failure to modify angiotensin I [data not shown]), was reduced by TCEP, digested by
immobilized chymotrypsin, and then the peptide fragments were allowed to remain in solution
for 24 h after removing chymotrypsin. After remaining in solution for 24 h, the modification
extent for Cys25 increased from 52 ± 2 to 91 ± 7%. Similarly, the modification extent for Cys80
increased from 15 ± 5 to 100% (Figure 3.1, blue bars and Table 3.1, column 6). It is important to

74

note that the modification extents for some of the other residues, especially His, Ser, and Tyr
residues, decrease over time, which is consistent with the Cys residues capturing the carbethoxy
group; although, the modification losses of some of these residues are partially due to hydrolysis
[21,22, 39, 40]. As a whole, these data are consistent with the idea that the free thiols of Cys can
capture a carbethoxy group from other DEPC-modified amino acids in solution.
DEPC modified His residue
unmodified His residue
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O
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O
HS

N

NH

HN

N
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DEPC modified Cys residue
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Scheme 1.Hypothesized mechanism of cysteine capture of carbethoxy-modified histidine.
3.3.2 Carbethoxy group capture by peptides in solution
To further test this idea, we examined the reactivity of unmodified cysteine-containing
peptides with other DEPC-modified peptides. Angiotensin I was reacted with DEPC, and the
reaction

was quenched by imidazole. Then, the cysteine-containing peptide ANP

(SLRRSSCFGGR) was added to the solution containing DEPC-modified angiotensin, and TCEP
was also added to minimize intermolecular disulfide formation between two ANP molecules. The
sample was then analyzed by LC/MS as soon as possible (Figure 3.3a) and after 24 h (Figure
3.3b). Figure 3.3 indicates that the cysteine-containing peptide ANP is able to capture a
carbethoxy group from angiotensin I after reacting with the peptide for 24 h. The chromatogram
in Figure 3.3a shows that no modification of ANP is observed when the sample is analyzed
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within 10 min; this is because no free DEPC is present in the solution and the capture reaction
has not occurred yet. After incubating the two peptides together for 24 h, however, 37 ± 2% of
ANP is found modified at Cys7 (Figure 3.3b, peak at retention time of 12.5 min). Tandem MS of
the peptide corresponding to this peak at 12.5 min confirms that the modification site on ANP is
Cys7 with no modification observed at the N-terminus (Figure 3.4). Importantly, if ANP is
reacted directly with DEPC for 1 min, both the N-terminus and Cys7 are found modified (Figure
3.5). In addition to modification of ANP at Cys7, the ion abundances of the peaks corresponding
to DEPC-modified angiotensin I decrease. For example, angiotensin I peaks corresponding to
modifications at His6 decrease in abundance. These decreases are likely due to cysteine capture,
but they also could be due to hydrolysis of the carbethoxylated residues as indicated above [22,
33, 39, 40]. One might argue that the hydrolysis product, ethyl hydrogen carbonate, could react
with the thiol group of Cys, but this product is not only unreactive with nucleophiles but is well
known to be highly unstable in water, like all alkyl hydrogen carbonates [41]. These experiments
with peptides further suggest that cysteine can capture a carbethoxy group from other DEPCmodified amino acids.
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Figure 3.3 Extracted ion chromatograms (EIC) of the products of the reaction of DEPC-modified
angiotensin I and the peptide ANP with TCEP added to prevent disulfide formation. Shown are
the products (a) after a 10 min reaction and (b) after a 24 h reaction. Chromatographic peaks
notated with a residue(s) having an asterisk indicate that the corresponding chromatographic
peak is the peptide labeled at only the indicated residue(s).
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Figure 3.4 Tandem mass spectrum of the ANP modified species with a retention time of 12.5 min
(see Figure 3.3b). Unmodified z2 and z4 ions, modified z6 to z9 ions along with unmodified c3 to
c6 ions and modified c7 to c10 ions confirm that Cys7 is the site of modification in the peptide
ANP.
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Figure 3.5 (a) Extracted ion chromatograms (EIC) of ANP (black) and DEPC-modified ANP
(red). Chromatographic peaks notated with a residue having an asterisk indicate that the
corresponding chromatographic peak is the peptide labeled at only the indicated residue. (b)
Tandem mass spectrum of modified ANP with a retention time of 13.2 min. Unmodified z2 to z4
ions and modified z5 to z10 ions along with unmodified c3 to c6 ions and modified c7 to c10 ions
confirm that C7 is the site of modification. (c) Tandem mass spectrum of modified ANP with
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retention time of 15.5 min. A series of unmodified z2 through z10 ions and modified c3 to c9 ions
confirm that the N-terminus is the site of modification.
We also investigated the possibility of capture by Cys in a peptide that forms a disulfide
bond. For this purpose we used the peptide semastatin (SPWTKCSATCGGGHYMRTR). Figure
3.6 shows the total ion chromatogram (TIC) of semastatin after reacting with DEPC at a 1:4
peptide:DEPC ratio. The reaction was quenched by adding imidazole, and no TCEP was added to
reduce the disulfide bond. Four different modification sites are identified by LC/MS/MS,
including Tyr15, His14, the N-terminus and Lys5. Peaks corresponding to peptides with two
DEPC modifications on the same peptide are also observed around 18 min as indicated in Figure
3.6. No modification of the two Cys residues is observed because the two Cys residues form a
disulfide bond and are therefore unreactive with DEPC. To test whether free Cys residues in
semastatin could capture the modification from another residue, TCEP was added after
quenching the DEPC reaction in order to reduce the disulfide bond before analysis. Figure 3.7
shows the resulting LC/MS data after letting the disulfide reduced peptide sit in solution for 10
min (Figure 3.7a) and 2 h (Figure 3.7b). As shown in the figure, there is some minor
modification at Cys6 and Cys10 even after 10 min, indicating that the capture reaction is fast for
this peptide; however, the data also shows that Tyr15, His14, the N-terminus, and Lys5 are still
modified. In addition, a peak is observed that corresponds to a peptide with two DEPC
modifications on the same peptide; MS/MS confirms that both Cys6 and Cys10 are modified in
the ion corresponding to this peak. After sitting in solution for 2 h, the modification levels at
Cys6 and Cys10 have increased quite noticeably, while the modifications at Tyr15 and His14 are
no longer measurable. Also the intensity of the peak that corresponds to a peptide with two
DEPC modifications at Cys6 and Cys10 also increased. The decrease in the modification extents
for Tyr15 and His14 could be due to the hydrolysis of the carbethoxylated residues [22, 36, 39,
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40] rather than capture of the carbethoxy group by the Cys residues. A control experiment,
however, shows that hydrolysis is not the primary cause (see Figure 3.8). Overall, these data
indicate that Cys residues can capture a modification from another residue but only when the Cys
residues are free thiols and not when they are part of a disulfide bond.

Figure 3.6 Total ion chromatogram (TIC) of semastatin modified by DEPC at a peptide: DEPC
ratio of 1:4 without TCEP added after the reaction. Chromatographic peaks notated with a
residue(s) having an asterisk indicate that the corresponding chromatographic peak is the peptide
labeled at only the indicated residue(s).
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Figure 3.7 Total ion chromatograms (TIC) of semastatin modified by DEPC at a peptide:DEPC
ratio of 1:4 with TCEP added after the reaction with DEPC (a) Products after allowing the
peptide to remain in solution for 10 min after TCEP addition and (b) 2 h after adding TCEP.
Chromatographic peaks notated with a residue(s) having an asterisk indicate that the
corresponding chromatographic peak is the peptide labeled at only the indicated residue(s).

Figure 3.8 Total ion chromatogram (TIC) of semastatin modified by DEPC at a peptide:DEPC
ratio of 1:4 with TCEP added 2 h after the reaction with DEPC. The sample was analyzed
immediately. This is a control experiment that demonstrates that the capture of the carbethoxy
group by the Cys residues is the primary cause of the decreases in the Tyr15 and His14
modification levels. The figure indicates that modification at Tyr15 and His14 is observed, while
no modification of these two residues is observed in the case when the sample was incubated
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with TCEP for 2 h as indicated in Figure 3.7(b). This result demonstrates that the decrease of the
modification for some of the residues is directly related with the existence of free thiolgoup.
Chromatographic peaks notated with a residue(s) having an asterisk indicate that the
corresponding chromatographic peak is the peptide labeled at only the indicated residue(s).
3.3.3 Avoiding carbethoxy transfer to cysteine
Avoiding the modification of disulfide linked or buried Cys residues is important for
maintaining accurate protein structural information from DEPC labeling experiments. As was
shown above for β2m, this can be done by not reducing the disulfide bond, but this, of course,
would lead to low digestion efficiency and a diminished ability to find modified amino acids. So,
we investigated the ability of iodoacetamide to prevent carbethoxy transfer to the free cysteine
residues that are produced after disulfide reduction. Iodoacetamide is commonly used in
proteomics to alkylate free thiols and prevent peptide fragments from forming disulfides after
digestion. So, we reasoned that this reagent might rapidly alkylate the free thiols, thereby
preventing transfer of the carbethoxy groups to the newly reduced Cys residues. The gray bars in
Figure 3.1 and the last column in Table 3.1 show that when iodoacetamide is added during the
β2m disulfide bond reduction step, no DEPC modification is observed at the two Cys residues.
Moreover, the modification percentages of all the other residues, as compared to the case when
no TCEP is added (Figure 3.1, compare green and gray bars and Table 3.1, compare columns 7
and 8), are mostly unaffected, indicating iodoacetamide has no effect on the DEPC labeled
peptides.
Additional experiments were also carried out to ensure that alkylation by iodoacetamide
does not displace DEPC labels from Cys residues that are properly labeled by DEPC. To test this
possible scenario, the peptide ANP was reacted with DEPC for 1 min at a 1:4 peptide: DEPC
ratio, and LC/MS/MS data indicate modifications at the N-terminus and Cys7. The percentage of
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peptides with a modification at the N-terminus was found to be 5 ± 1%, and the percentage of
modified Cys7 residues was found to be 3.8 ± 0.6%. To the same sample TCEP and
iodoacetamide were added and allowed to react for 30 min. After this 30 min reaction, the
remaining free thiols were modified 100% by iodoacetamide. The DEPC modification
percentages of the N-terminus and Cys7 were found to be almost identical to the percentages
measured before alkylation, with the N-terminus being modified 6 ± 1% and Cys7 modified 2.9
± 0.4%. These results indicate that, even with a vast excess of iodoacetamide, alkylation does not
displace a DEPC label from cysteine or other modified amino acids. Therefore, blocking cysteine
groups by iodoacetamide can effectively prevent label scrambling without influencing the
modification levels of solvent accessible free cysteine residues.

3.4 Conclusions
From the data presented here, we can conclude that disulfide linked cysteine residues do
not react with DEPC, but when a disulfide bond is reduced to form free thiols, these reduced
cysteines can capture carbethoxy groups from other modified amino acids. This process can
accelerate the loss of DEPC modification from certain amino acids, especially His, Ser, Thr, and
Tyr residues, and lead to less structural information. In addition, the modification of buried
cysteines can also lead to incorrect structural information about a protein. Hence, it is important
to avoid the transfer of carbethoxy groups to cysteine. Digesting the protein without adding a
reducing agent is one possible solution, but this decreases digestion efficiencies. A better solution
is to add iodoacetamide during the disulfide reduction step to alkylate free thiols, thereby
preventing transfer of carbethoxy groups from modified residues to cysteines. While the
described results are specific for DEPC labeling experiments, we predict that other electrophilic
84

labeling reagents could conceivably exhibit similar scrambling behavior.
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CHAPTER 4
COVALENT LABELING WITH ISOTOPICALLY ENCODED REAGENTS FOR
FASTER STRUCTURAL ANALYSIS OF PROTEINS BY MASS SPECTROMETRY
This chapter is part of a paper published as: Zhou, Y.; Vachet, R. W. Covalent Labeling with
Isotopically Encoded Reagents for Faster Structural Analysis of Proteins by Mass Spectrometry.
Accepted by Analytical Chemistry.

4.1 Introduction
Mass spectrometry (MS) has emerged as a valuable tool for studying the higher order
structure of proteins and protein complexes, especially in instances in which more commonly
used methods, such as NMR and X-ray crystallography, are not suitable due to protein size,
conformational flexibility, aggregation propensity, and/or limited sample quantity. Typically, to
obtain protein 3D structural information, MS is combined with H/D exchange [1-10], crosslinking [11-21], covalent labeling [22-30], or noncovalent labeling [31-33] to encode structural
information into the mass of the measured protein (or peptide fragments). Covalent labeling
combined with MS has seen increased interest in recent years because it provides information
about side chain solvent accessibility and is therefore particularly valuable for studying proteinprotein interfaces[24, 34-42]. In addition, as compared to H/D exchange and cross-linking,
reliably identifying modified protein sites is experimentally straightforward. Usually, fewer sites
on proteins are modified by covalent labeling reagents than in H/D exchange; however, the use
of hydroxyl radicals [23-28, 38-42] or other general modification reagents, such as
diethylpyrocarbonate (DEPC) [34-37, 43, 44], enable a higher percentage of a protein to be
probed and therefore a greater effective “resolution” to be obtained.
Structural information obtained from covalent labeling is reliable, though, only if the
structural integrity of a protein is preserved during the reaction. Because most covalent labels are
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relatively large compared to deuterium, for example, they can potentially distort a protein’s
structure upon reaction. Consequently, appropriate checks are required to ensure that the labeling
reaction preserves the protein’s structure and thus provides reliable information. Several methods,
such as circular dichroism (CD) spectroscopy, activity assays, and fluorescence spectroscopy,
have been used to check protein structure; however, these methods are often not sufficient for
monitoring the effect of modification on protein structure because they report on either global
structure (e.g. CD) or only a few regions of the protein (e.g. fluorescence spectroscopy and
activity assays). Previously, we have demonstrated that dose-response curves can be used to
reliably detect protein structural changes anywhere in the protein [34]. Such plots involve
measuring the extent of modification at each labeled site to determine labeling kinetics.
Measuring the kinetics of the labeling reactions provides a very sensitive way to monitor any
modification-induced structural changes caused by the covalent labels.
While this method is a sensitive and site-specific indicator of protein structural integrity,
it requires multiple LC/MS measurements to establish reliable kinetics and therefore can be
laborious and sample intensive. Here, we present a new approach based on isotopically encoded
reagents that allow labeling kinetics to be measured at each site in a single LC/MS experiment,
thus providing a faster and less sample intensive way to ensure protein structure integrity. To
demonstrate this new approach, we employ commercially available tandem mass tags (TMTs)
[45,46], which are commonly used in MS-based quantification experiments. The tags react with
lysine residues and the N-terminus, providing a good probe of protein surface structure.
Importantly, they contain isotopic reporter groups that are liberated during either collision
induced dissociation (CID) or electron transfer dissociation (ETD) experiments and can be used
to quantify modification extent. In effect, the TMTs allow simultaneous identification and
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quantification of covalent labeling sites and therefore allow us to produce entire dose-response
curves in a single LC/MS experiment.

4.2 Experimental Procedure
4.2.1 Materials
Immobilized chymotrypsin and triethylamine acetate (pH 8.0) were purchased from
Princeton Separations (Adelphia, NJ, USA). Human β-2-microglobulin (β2m) was obtained from
Lee Biosolutions, Inc. (St. Louis, MO, USA). Triethylammonium bicarbonate (TEAB), 50%
(w/w) hydroxylamine, iodoacetamide, tris(2-carboxyethyl)phosphine (TCEP), and equine
skeletal muscle myoglobin were obtained from Sigma-Aldrich (St. Louis, MO, USA). The
sixplex Tandem Mass Tags (TMTs) reagent kit and TMTzeroTM (TMT0) labeling reagent were
purchased from Thermo Scientific (Rockford, IL, USA). Methanol, acetonitrile, and acetic acid
were obtained from Fisher Scientific (Fair Lawn, NJ, USA). Centricon molecular weight cutoff
(MWCO) filters were from Millipore (Burlington, MA, USA). Deionized water was generated
with a Millipore (Burlington, MA, USA) Simplicity 185 water purification system.

4.2.2 Sample Preparation and Reaction Conditions
The TMT0 modification reagent, which has no isotope substitutions, was used to optimize
and validate the reaction conditions that were eventually conducted with the TMTsixplexTM
(TMT6) reagent set. The TMT reagents (TMT0 or TMT6) were first dissolved in acetonitrile.
Proteins (2 µM) were then covalently modified with the TMT reagents at varying concentrations
(0.04 – 0.24 mM) in a 20 mM TEAB solution at pH 7.4. The reactions were then quenched after
1 min (myoglobin) or 10 s (β2m) by adding a hydroxylamine solution (5 wt % in 200 mMTEAB).
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Before proteolytic digestion, the modified proteins were purified using a 10,000 MWCO filter.
β2m, which has a disulfide bond, was reacted with TCEP (protein:TCEP=1:40 molar ratio) to
reduce the disulfide bond. Iodoacetamide was added simultaneously at room temperature for 30
min in the dark to alkylate the reduced Cys residues [35]. Both β2m and myoglobin were
incubated with 10% (vol/vol) acetonitrile at 50 ºC for 45 min prior to digestion. The resulting
samples were then digested by immobilized chymotrypsin (enzyme/substrate ratio of 1:10) at 37
ºC. After 2 h, the reaction mixture was centrifuged for 2 min at 9000 relative centrifugal force to
separate the enzyme from the protein. Digestions after the parallel reactions with the TMT6
reagents were done in parallel and then pooled for immediate analysis by LC-MS/MS.

4.2.3 Instrumentation
The MS analyses were carried out on a Bruker AmaZon (Billerica, MA, USA)
quadrupole ion trap mass spectrometer, which is equipped with an electrospray ionization source.
Typically, the electrospray needle voltage was kept at ~4 kV, and the capillary temperature was
set to 250 ºC. Either collision-induced dissociation (CID) in the PANTM mode or electron
transfer dissociation (ETD) was used to obtain tandem mass spectra. Because CID on quadrupole
ion traps typically suffers from a limited product ion range, the reporter ions from the TMT6
reagents are often not measurable for larger peptide ions during standard CID experiments. To
overcome this limitation, we used the panorama (PANTM) mode to enable lower m/z ions to be
observed in the CID spectra. The PAN mode works in a way that is comparable to the pulsed Q
dissociation [47] and HASTE [48] methods described previously. For the CID PANTM mode, the
activation was set to 70%, and the low CID cutoff was set to 17%. For the ETD experiments,
fluoranthene radical anions were used with an accumulation time of 10 ms. Low m/z cutoff
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(LMCO) values ranging from 50 to 100 and reaction times ranging from 50-180 ms were used.
The MS and MS/MS scan ranges were 100-3000 m/z unless otherwise stated. An HP1100 HPLC
system (Agilent, Wilmington, DE, USA) with a Discovery C18 column (15 cm × 2.1 mm, 5 µm
particle size; Supelco, St. Louis, MO, USA) was used for HPLC analysis. Peptide fragments
from the proteolytic digests were eluted using a linear gradient of methanol containing 0.1%
acetic acid that increased from 10% to 100% methanol over 30 min at a flow rate of 0.25
mL/min

4.3 Results and Discussion
4.3.1 TMT for dose-response curves
Previously we have demonstrated that dose-response plots are reliable ways to ensure the
structural integrity of a protein during covalent labeling reactions. These plots rely on measuring
the modification rates of individual peptide fragments and looking for deviations from linearity
as a way to indicate the range of label concentrations that maintain a protein’s structure. The
reaction of a covalent label with a protein follows second-order kinetics under the conditions we
typically use [34] and can be described by equation 1, where [P]0 is the initial unmodified protein
concentration, [X]0 is the initial covalent label concentration, [P] is the unmodified protein
concentration at time t, [X] is the labeling reagent concentration at time t, and k is the secondorder rate coefficient. Typically we use a constant reaction time, and hence, a plot of

vs.

will result in a straight line if the protein’s structure remains unchanged over

a range of reagent concentrations. Deviations from linearity indicate a change in protein
structure, as hypothetically illustrated in Scheme 4.1. In our usual protocol, we react a given
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protein with at least six different concentrations of the covalent labeling reagent, with three
replicates at each concentration. Therefore, a minimum of 18 HPLC-MS runs are conducted.

(1)

Scheme 4.1 Hypothetical dose-response plot for a second-order reaction indicating that the
protein/peptide’s structure deviates at higher reagent (X0) concentrations
While this approach is very effective for finding reaction conditions that ensure protein
integrity and the measured rates provide quantitative insight into the solvent accessibility of a
given residue, this approach is very time consuming. Consequently, we hypothesized that
parallel reactions of different concentrations of isotopically encoded reagents could dramatically
shorten the time frame of our approach by minimizing the number of LC-MS runs. Scheme 4.2
shows the experimental steps to implement this isotopic labeling method: (a) each isotopically
encoded reagent is reacted at a different concentrations with the protein under otherwise identical
conditions; (b) the resulting products are digested, pooled together, and analyzed by LC-MS/MS;
and (c) the ion abundances of the different m/z that arise from the isotopically encoded reagents
are used to generate a dose-response plot that helps ensure the structural integrity of the protein.
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Scheme 4.2 Experimental work-flow for TMT labeling strategy. (a) A protein is labeled in
parallel with different concentrations of isotopically encoded reagents. (b) The protein samples
are digested and pooled for LC-MS/MS analysis. (c) MS/MS is used as a readout of the
isotopically labeled peptides.

To explore the feasibility of this idea, we investigated tandem mass tags (TMTs) as the
isotopically encoded covalent labeling reagents. TMTs comprise a set of structurally identical
tags that mainly label the free N-terminus and lysine side chains (Scheme 4.3). After the labeling
reaction, the protein and eventual peptide digestion products will have a mass shift for every
TMT molecule that is added. The isotopically encoded regions of the molecule that carry the
information necessary to generate the dose-response plots are measured at the MS/MS, not MS,
stage of the experiment, meaning that the pooled solution-phase reaction products give rise to the
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same m/z ratio for the labeled peptides (Scheme 4.2 (c)). A common measured m/z product ion
during the MS stage of the experiment avoids diluting the ion signal across multiple reaction
products and ensures co-elution of the products. During MS/MS, dissociation of the modified
peptides from the pooled reactions gives rise to reporter ions at different m/z ratios whose
relative ion abundances contain information about the extent of reaction with the different label
concentrations and can be used to generate the dose-response plots (Scheme 4.2 (c)). The TMTs
have been designed to give rise to product ions in a m/z region that is typically devoid of peptide
product ions.

97

CID

(a)

O

O

O

N
N
H

ETD

O
O

Reporter ion

Mass normalization group

Reactive group

O

(b)

O

O

N
N
H

O
O

TMT

O

Lysine

N

NH
HC

HC

NH2

C
H2

O

NH
N
H

N
H

C
H2

O C

O C

Lysine

CID

ETD
H

m/z 114

N

H

(c)

O
O
N
∗

O

∗

O
∗
N
H

∗

∗

O
∗

∗

∗

N

∗

∗ O

∗

O
∗

∗

O
O

∗

ETD: 116
CID: 128

O
O

O

∗

∗
N
H

ETD: 118
CID: 130

∗

∗
N
H

O

∗

ETD: 115
CID: 127

N

O
O

∗

O

O

O

∗

O
N
H

∗

ETD: 117
CID: 129

O

∗

N
H

O

∗

ETD: 114
CID: 126
O

O

∗N
∗ O
O

∗N

m/z 126

N

∗
∗N

O
O

O
N
H

O
O

∗

TMT6

ETD: 119
CID: 131
Fragmentaion sites

ETD
CID

Scheme 4.3 (a) General structure of the TMT reagents. (b) Reaction of TMT with lysine and the
reporter ions that result after MS/MS, by ETD or CID. (c)Structure, isotope position, MS/MS
fragmentation sites and CID/ETD reporter ions for TMT6.
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The ability of the TMT reagents to enable accurate dose-response plots to be constructed
was tested using the TMT sixplex (TMT6), which has five isotopic substitutions per tag (see
Scheme 4.3 (c)). These labeling reagents give a mass increase of 229 for every TMT that is
added and generate reporter ions at m/z 126 through m/z 131 for CID and m/z 114 through 119
for ETD (Scheme 4.3 (c)). The relative abundances of these reporter ions are used to measure the
modification rate of a given labeled amino acid (in a given modified peptide) and determine the
reagent concentrations that ensure the structural integrity of the protein.

4.3.2 Reaction equation for TMT6
To simplify data analysis, the TMTs were reacted with proteins of interest under pseudofirst order conditions (equation 2) in which the isotopically encoded labeling reagents had
concentrations that exceeded protein concentrations by at least 20 times.

(2)
Using the ion abundances for the unmodified (Iunmodi) and modified (Imodi) peptides, equation 2
can be converted to equation 3.

(3)
If only one isotopomer of the TMTs is used, Iunmodi and Imodi are easily determined from the mass

spectrum, and a plot of

would give a straight line when the

protein’s structure remains unchanged and would deviate from linearity at high concentrations
99

when the protein’s structure changes. If all six TMTs are used in parallel reactions and the
digested products are mixed for LC-MS analysis, then the data analysis is slightly more
complicated. The ion abundances of the unmodified (i.e. Iunmodi) peptide cannot be directly
related to each TMT label because it carries no information about the reaction solution from
which it came. The modified peptide ion abundance (i.e. Imodi), however, does contain the
necessary information, but it is not revealed until the modified peptide is dissociated during
MS/MS (Scheme 4.2(c)). As an example, the extent of modification for the TMT that gives rise
to a product ion at m/z 126 for CID can be determined by equation 4, where in indicates the ion
abundance of each reporter product ion.

(4)
If we assume that the total peptide amount is the same in each of the parallel modification
reactions, then equation 5 can be used together with equation 4 to generate equation 6. Assuming
the peptide amounts are identical is reasonable because each reaction is done with identical
protein concentrations, and the proteins are digested under identical conditions.

=

(5)

(6)

We can then use equations 4, 5, and 6 to arrive at an expression (equation 7) that uses the
measured product ion abundances to determine the percentage of the modified peptide that forms
by reaction of a given TMT label.
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(7)

Putting this into a pseudo first-order reaction expression leads to equation 8.

(8)

If equation 8 is then plotted as a function of the concentrations used in each individual
TMT reaction, a dose-response plot will be created. In this plot a straight line will be obtained
for the range of TMT concentrations over which the protein’s structure remains unchanged, just
as in the previous approach for constructing dose-response plots [34]. The protein’s structure is
distorted when the plot deviates from linearity.

4.3.3 Reporter ions for dose-response curve
The suitability of this isotopic encoding approach was initially tested with the protein β2-microglobulin (β2m). In parallel reactions, the protein (2 µM) was reacted with 0.04 mM, 0.06
mM, 0.08 mM, 0.10 mM, 0.12 mM, and 0.16 mM of the TMT sixplex reagents, with the reagents
having the more massive reporter ions (see Scheme 4.3) used at increasingly higher
concentrations. After the 10 s reactions were completed, the protein was digested, pooled and
analyzed by LC-MS/MS to identify the modified sites and determine the rate of modification. As
an example of the data that is obtained, Figure 4.1a shows the CID mass spectrum of the peptide
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fragment SRHPAENGKSNF, which was found to be modified at Lys19. The inset of Figure 4.1a
shows the relative abundances of the reporter ions as centroid spectra because such centroid
spectra more accurately indicate ion abundances. The ion abundances of these reporter ions are
then plugged into equation 8 to produce a dose-response plot for this peptide (Figure 4.1b). At
TMT concentrations equal to or below 0.10 mM, a linear relationship is observed, suggesting
that the protein’s structure is maintained during the covalent modification reactions at these
lower concentrations. Deviations from linearity occur at TMT concentrations above 0.10 mM,
which implies that the protein’s structure is distorted at these higher TMT concentrations. The
rate coefficient, k, obtained from these data is 0.8 ± 0.1 s-1. The plotted values that result in this
reaction rate coefficient are included in Table 4.1.
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Figure 4.1 (a) CID tandem mass spectrum of the [M+4H+TMT6]4+ ion of the peptide fragment
SRHPAENGKSNF, acquired using the PAN mode (see experimental section for details). A
series of unmodified b ions from b2 to b8, modified b9 b10 and b11 ions, unmodified y2 and
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modified y4 and y6 ions confirm that Lys19 is the site of modification. The product ions with an
asterisk are the product ions that contain the TMT6 modification. The inset is an enlarged view of
the reporter ion region. (b) Dose-response plots for the peptide fragment (SRHPAENGKSNF)
obtained by plugging the reporter ion abundances at m/z’s 126 to 131 into equation 8. The k
value is obtained from the slope and is corrected using equation 2.
Table 4.1 The TMT6 concentration and the
value for peptide fragment
(SRHPAENGKSNF) from β2m under PAN fragmentation. This data is used to fit the pseudofirst order reaction. All the experiments were repeated three times, and the means and standard
deviations are reported.
[TMT] mM
0.04
0.06
0.08
0.1
0.12
0.16

-0.11 ± 0.06
-0.24 ± 0.04
-0.40 ± 0.05
-0.6 ± 0.1
-0.6 ± 0.1
-0.7 ± 0.1

To validate the data obtained with this isotope encoding method, we reacted β2m with the same
six concentrations of the non-isotopically enriched TMT reagent (i.e. TMT0) and carried out
separate LC-MS/MS analyses for each reaction concentration. Figure 4.2 is the resulting doseresponse plot for the same peptide in Figure 4.1 (i.e. SRHPAENGKSNF). Because the reaction
products from each concentration are analyzed by separate LC-MS experiments, the much
simpler equation 3 is used to generate the plot in Figure 4.2. The results in Figure 4.2 are in very
good agreement with the results shown in Figure 4.1. At TMT concentrations equal to or below
0.10 mM, a linear relationship is observed, and deviations from linearity occur at TMT
concentrations above 0.10 mM. Moreover, the rate coefficient (k = 0.7 ± 0.1 s-1) is essentially
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identical for this peptide. The plotted values for each TMT concentration are included in Table
4.2.

Figure 4.2 Dose-response plot for the proteolytic fragment SRHPAENGKSNF after reaction
with the TMT0 reagent. The k value is obtained from the slope and is corrected using equation 2.

Table 4.2 The TMT0 concentration and the
value for peptide fragment
(SRHPAENGKSNF) from β2m. This data is used to fit the pseudo-first order reaction. All the
experiments were repeated three times, and the means and standard deviations are reported.
[TMT] mM
0.04
0.06
0.08
0.1
0.12
0.16

-0.4 ± 0.1
-0.49 ± 0.04
-0.7 ± 0.1
-0.8 ± 0.1
-0.77 ± 0.08
-1.1 ± 0.2

While the isotopic encoding approach appears to be valid for at least one modification site on
β2m, confidence in this approach requires that all labeled sites be validated. A comparison of the
data for all the sites, however, was made challenging by an unexpected interfering product ion at
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m/z 129 that is observed in the CID spectra of several peptides. We found that peptides with an
unmodified lysine residue generate a product ion at m/z 129 that overlaps with one of the
reporter ions from the TMT6 set of reagents. The result is that the ion abundances of the reporter
ions from CID could not be confidently used in some cases. The CID spectrum of the peptide
fragment KNGERIEKVEHSDL, modified at Lys41, illustrates this fact (Figure 4.3). This
peptide has two lysine residues that can both be modified, and each modified form is separated
by LC. CID of the peptide modified at Lys41 by the TMT6 set of reagents reveals reporter ions in
the expected m/z region (inset in Figure 4.3 (a)); however, the ion at m/z 129 peak has an
unexpectedly high abundance relative to the other reporter ions. Upon observing the
unexpectedly high abundance of m/z 129, we surmised that the ion at this m/z ratio might be a
mixture of the reporter ion at m/z 129 and another interfering product ion at the same m/z.
Indeed, m/z 129 is a common low mass product ion found in the CID spectra of lysinecontaining peptides, and the presence of the unmodified Lys48 might lead to this product ion.
CID of the same peptide (KNGERIEKVEHSDL) labeled at Lys41 with the TMT0 reagent
confirms that the interfering ion does not arise from the modification reagent (Figure 4.4(b)), as
the TMT0 reagent should only produce a reporter ion at m/z 126. The product ion at m/z 129 is
even generated after CID of the unmodified peptide (Figure 4.4(a)), which further establishes
that this ion is not caused by the TMT6 reagent. Overall, we found the interfering ion to arise in
peptides containing two or more lysine residues, with one or more of the lysines remaining
unmodified.
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Figure 4.3 (a) CID mass spectrum of the [M+4H+TMT6]4+ ion of the peptide fragment
KNGERIEKVEHSDL, acquired using the PAN mode (see experimental section for details). A
series of modified b3 to b13 ions, and a series of unmodified y2 to y12 ions confirm that Lys41 is
the site of modification. The inset is an enlarged view of the reporter ion region. (b) ETD mass
spectrum of the [M+4H+TMT6]4+ ion of the peptide fragment KNGERIEKVEHSDL. A series of
modified ions from c1 to c13 and a series of unmodified ions from z4 to z13 confirm that Lys41 is
the site of modification by TMT6. The inset is an enlarged view of the reporter ion region. In all
spectra, the product ions with an asterisk are the product ions that contain the TMT modification.
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Figure 4.4 (a) CID tandem mass spectrum of the [M+4H]4+ ion of the peptide fragment
KNGERIEKVEHSDL from β2m, acquired using the PAN mode (see experimental section for
details). A series of b and y ions confirmed the sequence of the peptide fragment. (b) CID mass
spectrum of the [M+4H+TMT0]4+ ion of thepeptide fragment KNGERIEKVEHSDL in the m/z
range around the reporter ions. This spectrum was acquired using the PAN mode.
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The solution to the problem caused by this interference ion is to dissociate the modified
peptides via ETD. The effectiveness of this solution is exemplified in the ETD spectrum of the
same peptide (i.e. KNGERIEKVEHSDL) modified at Lys41. The inset in the figure shows the
reporter ions at m/z 114 through m/z 119. No interfering ions appear in the reporter ion range of
this spectrum or the ETD spectrum of the unmodified peptide (data not shown). Thus, ETD can
provide interference free data. Using ETD to dissociate the peptides with interfering ions and
CID to dissociate all other peptides, the isotope encoding method can now be validated for all
eight labeled sites in β2m. Indeed, Table 4.3 shows good agreement between the rate coefficients
obtained by the more labor intensive TMT0 analysis (TMT0 column in Table 4.3) and the 6x
faster TMT6 analysis (TMT6/CID or TMT6/ETD columns in Table 4.3).

Table 4.3 Rate coefficients of TMT-modified amino acids of β2m and myoglobin.
β2m
modified sites

TMT0

N-term.
K6
K19
K41
K48
K58
K75
K91/K94

0.010 ± 0.001
0.10 ± 0.01
0.7 ± 0.1
0.009 ± 0.001
0.016 ± 0.002
0.10 ± 0.01
0.15 ± 0.02
0.18 ± 0.03

N-term.
K16
K42
K62/K63
K77/K78/K79
K87
K145
K147

0.057 ± 0.002
0.025 ± 0.005
0.028 ± 0.002
0.077 ± 0.007
0.016 ± 0.001
0.037 ± 0.007
0.008 ± 0.001
0.048 ± 0.007

a

TMT6
CID
CID 100-150
ETD
--b
-0.014 ± 0.003
--0.09 ± 0.03
0.8 ± 0.1
0.96 ± 0.04
0.8 ± 0.1
--0.019 ± 0.002
--0.022 ± 0.003
0.058 ± 0.008 0.092± 0.008
-0.20 ± 0.02
0.17 ± 0.03
---0.20 ± 0.02
Myoglobin
---0.046 ± 0.007 0.042 ± 0.003 0.038 ± 0.003
0.023 ± 0.003 0.023 ± 0.002 0.020 ± 0.003
--0.080 ± 0.007
--0.015 ± 0.002
--0.043 ± 0.003
0.012 ± 0.002 0.010 ± 0.002 0.009 ± 0.007
0.042 ± 0.007 0.040 ± 0.003
--

[TMT]
a
ETD 100-150 mM
0.017 ± 0.003 0.12
0.09 ± 0.03
0.12
0.7 ± 0.1
0.10
0.012 ± 0.001 0.12
0.020 ± 0.002 0.12
-0.10
-0.10
0.17 ± 0.01
0.10
0.070 ± 0.002
0.035 ± 0.005
0.017 ± 0.001
0.09 ± 0.01
0.012 ± 0.002
0.040 ± 0.008
0.010 ± 0.005
--

0.20
0.16
0.16
0.16
0.20
0.20
0.16
0.12

The TMT concentration above which the pseudo first-order reaction deviates from the linearity.

109

b

-- indicates that the data are not applicable either because there are interfering ions or the
charge state is too low for efficient ETD.

While ETD avoids the interference ion that complicates data analysis in the TMT6
labeling experiments, the longer dissociation times required during the ETD experiment can limit
the number of mass spectra that are obtained as an LC peak elutes. This longer duty cycle makes
it challenging to analyze peptides with low levels of modification or low ion abundances. For
example, the peptide fragment GLSDGEWQQVL, which is labeled at the N-terminus, has a
lowion abundance when modified by the TMT6 reagent. As such, the ETD spectrum does not
provide a complete collection of reporter ions (Figure 4.5a). To increase the effective signal for
peptides like this one, we investigated shortening the quadrupole ion trap scan range used in
these experiments to obtain more spectra during the same amount of time, and thus obtain higher
quality spectra. Instead of acquiring data from m/z 100 to 3000, we explored whether a shorter
scan range (i.e m/z 100 to 150) would improve the signal in the reporter ion region. This shorter
scan range increases the number of spectra acquired per unit time by at least a factor of 2 and
thus provides better ion statistics and more reliable reporter ion information (Figure 4.5b). A
drawback of this approach, however, is that two LC-MS/MS runs are needed; one to identify the
labeled residues using a broader scan range and a second to obtain the reporter ion information
necessary to construct the dose-response plots for the sites that are modified to a minor extent.
As Table 4.1 shows the shorter scan range provides excellent rate coefficient data that is
comparable to the more involved analysis with the TMT0 reagent.
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Figure 4.5 (a) ETD mass spectrum of the [M+3H+TMT6]3+ ion of the peptide fragment
GLSDGEWQQVL. A series of modified c1 to c9 ions and a series of unmodified z3 to z10 ions
confirm that the N-terminus is the site of modification. The product ions with an asterisk are the
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product ions that contain the TMT modification. The inset spectrum is an enlarged view of the
reporter ion region, showing that poor ion statistics leads to insufficient information to construct
a reliable dose-response plot. (b) ETD mass spectrum of the [M+3H+TMT6]3+ ion of the peptide
fragment GLSDGEWQQVL, acquired using a shorter scan range (from m/z 100 to 150).

To demonstrate that this isotope encoding method can work with another protein, we also
investigated the covalent labeling of myoglobin. The results for this protein are also listed in
Table 4.3. In comparing the results from the more involved TMT0 experiment, which requires
six LC-MS/MS runs per experiment, and the TMT6 experiment, which requires one (or two) LCMS/MS runs per experiment, we find very good agreement in the dose-response plots for
myoglobin, as indicated by the measured rate coefficients. To emphasize the time and sample
savings involved in the isotope encoding approach, it should be noted that a total of 18 LCMS/MS runs each were required to obtain the TMT0 results for myoglobin and β2m, while only
three LC-MS/MS runs each were required to obtain the TMT6 results. Together the data for these
two proteins indicate both the robustness and greater efficiency of this approach.
Finally, it should be noted that while TMT reacts most readily with N-termini and lysine
residues, it can also modify other residues, such as serine, threonine and tyrosine residues. In fact,
we found that at higher TMT concentrations some serine and tyrosine residues were modified. In
each case, though, these residues were modified at TMT concentrations that were too high to be
useful as they were modified under conditions in which the protein’s structure had been distorted.
Interestingly, CID and ETD both produce the same set of reporter ions for these modified
residues as they do for lysine. It is quite possible that for other proteins serine, threonine, and
tyrosine residues could be modified in a structurally informative way, thereby increasing the
information available with the TMT reagent.
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4.4 Conclusions
We have developed a new strategy for ensuring protein structural integrity during covalent
labeling reactions. Our new strategy uses isotopically encoded covalent labeling reagents to
simultaneously investigate the range of covalent labeling reagent concentrations that will provide
information about the surface structure of the protein while avoiding modification-induced
structural changes. To illustrate this new strategy, we used tandem mass tags (TMTs) to
isotopically encode the desired reactivity information. In using the TMTs, MS/MS is used to
generate reporter ions that provide a readout of a given site’s reactivity with the covalent labeling
reagent. This new approach is faster and requires less sample than previous approaches based on
dose-response plots. We have validated this new approach by comparing the isotope encoding
method to another more time-consuming method of ensuring protein structural integrity and
found that the new approach provides comparable results. In addition, we find that both CID and
ETD can generate the required reporter ions. In cases where a peptide fragment contains an
unmodified lysine residue, though, ETD provides more reliable data by avoiding the formation
of an interfering ion. Overall, this new strategy represents a faster and more efficient way to
ensure the accuracy of covalent labeling/MS experiments. We envision that this strategy could be
used with other covalent labeling reagents that are isotopically labeled and could be used in a
different format where MS, instead of MS/MS, is used to provide a readout of the modification
reactivity.
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CHAPTER 5
MONITORING PROTEIN STRUCTURAL CHANGES AFTER EXPOSURE TO
DEGRADATION CONDITIONS BY COVALENT LABELING AND MASS
SPECTROMETRY
5.1 Introduction
The pharmaceutical industry has been transformed by the successful use of biologics such
as therapeutic proteins [1]. Therapeutic proteins have acquired a very important role in the
treatment of various diseases such as diabetes, cancer, and inflammatory diseases. If such
proteins are administered with after have undergone covalent or non-covalent changes to their
structure, however, they would be less effective or could cause unwanted side effects,
immunogenicity and allergic reactions. Therefore, a strong awareness to strive for highly pure
and stable proteins products has emerged. High purity starts with downstream processing of
therapeutic proteins [2]. In order to reasonably design a drug, the bulk material has to have an
acceptable level of impurities, be stable and have robust formulations. Because therapeutic
proteins are exposed to various types of stress during production, shipment, storage and final
administration, the robustness of the formulations against external stress factors is extremely
important. These stress factors include temperature fluctuations, elevated temperatures, freezing,
thawing, oxygen exposure, and mechanical stress.
To monitor how therapeutic proteins change under external stress, a forced degradation
study can be carried out. Such studies involve processes in which the natural degradation rate of
a pharmaceutical product is increased by the application of an additional stress [3]. Forced
degradation studies are an integral part of the development of therapeutic proteins. The purpose
may vary depending on the application area and the phase of development. These studies can
help identify reactions that cause degradation of pharmaceutical products, demonstrate
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specificity when developing stability-indicating methods, and provide information about the
degradation pathways and degradation products that could form during storage. Besides, forced
degradation studies are also used to develop analytical methods to determine the degradation
products formed during long-term stability studies [4].
The experimental protocol for forced degradation studies are carried out in several ways
based on real conditions. Improper shipment, storage or handling or deviations can cause
elevated temperatures. In this case, thermal degradation study can be carried out. Generally
speaking, the rate of a reaction increases with increase in temperature. Drugs are susceptible to
degradation at higher temperature. The effect of temperature on thermal degradation is studied
through Arrhenius equation:

where k is specific reaction rate, A is frequency factor, Ea is the activation energy, R is the gas
constant and T is temperature. Thermal degradation studies are usually carried out for as short as
1 h and as long as 1-2 months at 40 ºC to 80 ºC, with the most widely used temperature in the 70
ºC to 80 ºCrange [3, 5]. Temperatures higher than 800C may not produce predictive degradation
pathways [6]. Contact with oxygen, for example exposure to air and/or dissolved O2, or light can
lead to oxidative stress. This process can be monitored using oxidative conditions with proteins
incubated with hydrogen peroxide. Hydrogen peroxide is a very common oxidant used to
produce oxidative degradation products. It is often used in the concentration range of 3-30% at
room temperature with a time range of several hours to several days. The other forced
degradation conditions include: acid conditions, in which solutions are mixed with 37% HCl to
reach a pH of 2.0 for certain amounts of time before being neutralized with NaOH; basic
conditions, in which solutions are treated with NaOH to reach a pH 10.0 before being neutralized
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with HCl; and UV irradiation, in which solutions are exposed to 254 nm light for 24 hours or
longer.
Appropriate analytical techniques are required to detect any structural changes caused by
forced degradation conditions. The two most commonly used techniques for protein structure
determination are X-ray crystallography and NMR. Unfortunately there are major problems
when applying these technologies for the purpose of higher order structure comparability studies.
X-ray crystallography for example is impractical for routine testing for the following two reasons:
first, the sample may not be crystallized owing to the presence of PTMs or disordered regions of
the protein; secondly, it is too time-consuming. While for NMR, the large size of therapeutic
proteins and the relatively low sensitivity of the NMR signals make this technique impractical
for routine use. Other biophysical techniques such as circular dichroism (CD), fluorescence
spectroscopy, differential scanning calorimetry, isothermal calorimetry and size exclusion
chromatography (SEC) are also used to study protein higher order structure [7, 8]. These
methods generally provide only global structural information that is an average over the entire
structure of the therapeutic protein. Thus, these techniques are not well suited for detecting small
changes in protein structure. The use of mass spectrometry combined with labeling techniques
such as hydrogen deuterium exchange (HDX) [9] and covalent labeling [10] can be valuable
tools in detecting small changes in the higher-order structure of therapeutic proteins. HDX can
be used to monitor structural and dynamic aspects of proteins in solution and can localize where
changes exist in specific regions of the protein. For example, this technique was used to study the
conformation and conformational dynamics of a recombinant immunoglobulin G1 monoclonal
antibody. The higher-order structure change after removing its glycans can be monitored by
HDX-MS [11, 12]. Generally speaking, HDX is a very powerful technique for examining
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changes in protein secondary structure and dynamics in therapeutic proteins [13]; however, this
technique is very challenging due to the reversible nature of the HDX process.
Covalent labeling when combined with MS is another method that can be used to map
protein structure, by providing insight into protein surface structure in particular. Protein
conformational changes an affect surface topology, and covalent labeling can monitor such
structural changes. While it typically provides lower structural resolution than HDX/MS,
covalent labeling is much easier to perform and provides complementary side chain information.
To our knowledge, however, covalent labeling with MS has not been investigated as a tool for
monitoring structural changes to proteins upon exposure to degradation conditions. In this
chapter, we examine covalent labeling combined with mass spectrometry as a new approach to
monitor the structural changes of proteins after exposure to forced degradation conditions. Two
different forced degradation conditions, thermal degradation and oxidative degradation, were
investigated. The feasibility of the method is explored using β-2-microglobulin as a model
system.

5.2 Experimental Procedure
5.2.1 Materials
Human β-2-microglobulin (β2m) was purchased from Fitzgerald Industries International,
Inc (Concord, MA). Immobilized chymotrypsin and triethylamine acetate (pH 8.0) were
purchased from Princeton Separations (Adelphia, NJ). Diethylpyrocabonate (DEPC), imidazole,
iodoacetamide, ammonium bicarbonate, tris(2-carboxyethyl)phosphine (TCEP), and Glu-C were
obtained from Sigma-Aldrich (St. Louis, MO). Hydrogen peroxide (H2O2), ammonium acetate,
methanol, acetonitrile, and acetic acid were obtained from Fisher Scientific (Fair Lawn, NJ).
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Centricon molecular weight cutoff (MWCO) filters were from Millipore (Burlington, MA).
Deionized water was generated from a Millipore (Burlington, MA) Simplicity 185 water
purification system.

5.2.2 Sample Preparation
The proteins were prepared in 50 mM ammonium acetate at pH 7.4, and then were
incubated at 75 ºC for 30 min or 1 day for thermal degradation conditions. Heating experiments
were also conducted in the presence of a reducing agent, and in this case TCEP was added after
the protein was heated. Oxidative conditions were carried out by incubating the protein in the
presence of 3% H2O2 or 10% H2O2 (w/w) at room temperature for 1 day. After the forced
degradation conditions, the proteins were reacted with DEPC. Stock solutions of DEPC were
prepared in acetonitrile. The DEPC reactions of proteins were performed for 1 min at 37 ºC and
were initiated by adding DEPC in a molar excess of 2.5. The total reaction volume for the
experiments was 100 µL, and the total amount of acetonitrile added was 1%. The reactions were
quenched after 1 min by adding 10 mM imidazole [14]. The modified proteins were purified
using a 10,000 MWCO filter before proteolytic digestion. Since β2m has a disulfide bond, TCEP
(protein:TCEP=1:40 molar ratio) was added to reduce the disulfide bond and iodoacetamide was
added simultaneously at room temperature for 30 min in the dark to alkylate the reduced Cys
residues. The resulting samples were incubated with 10% (vol/vol) acetonitrile at 50 ºC for 45
min prior to digestion by immobilized chymotrypsin (enzyme/substrate ratio of 1:10) at 37 ºC.
After 2 h, the reaction mixture was centrifuged for 2 min at 9000 relative centrifugal force to
separate the enzyme from the protein. After that, the samples were immediately analyzed by LCMS.
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5.2.3 Instrumentation
All the MS analyses were carried out on a Bruker AmaZon (Billerica, MA, USA)
quadrupole ion trap mass spectrometer equipped with an electrospray ionization source.
Typically, the electrospray needle voltage was kept at ~4 kV, and the capillary temperature was
set to 250 ºC. Either collision-induced dissociation (CID) or electron transfer dissociation (ETD)
was used to obtain tandem mass spectra. For HPLC analysis, an HP1100 HPLC system (Agilent,
Wilmington, DE, USA) with a Discovery C18 column (15 cm × 2.1 mm, 5 µm particle size;
Supelco, St. Louis, MO, USA) was used. Peptide fragments from the proteolytic digests were
eluted using a linear gradient of methanol containing 0.1% acetic acid that increased from 10%
to 100% methanol over 30 min at a flow rate of 0.25 mL/min. For SEC experiments, the protein
was separated using a SuperSW2000 30 cm ×4.6 mm column (GE Healthcare Biosciences,
Piscataway, NJ) installed on an Agilent HP1100 series HPLC system (Wilmington, DE). Before
injection of the sample, the SEC column was first equilibrated with a 20 mM ammonium acetate
mobile phase (pH = 7.4) at a 0.035 mL/min flow rate for 1 h. 20 µL of the protein sample, after a
given degradation condition, was injected into the sample loop. A variable wavelength detector
set at 214 nm was used for detection.

5.3 Results and Discussion
5.3.1 β2m as a model protein to explore the feasibility of the method
Thermal degradation studies were carried out at 75 ºC, which is a common temperature
used for such studies [3]. Incubation times of 30 min and 1 day were selected to monitor the
structural change of protein at short and long heating times. To test whether the method could
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monitor more significant degradation of the protein, TCEP was added after heating to reduce
β2m’s single disulfide bond. β2m was also exposed to oxidation conditions by mixing the protein
with 3% H2O2 or 10% H2O2 (w/w) at room temperature for 1 day. Thermal and oxidative
conditions were selected because these two conditions are two of the most commonly used
forced degradation conditions because they mimic real-world situations. For example, during
storage or shipment of therapeutic proteins, samples are often exposed to elevated temperatures
or to air and/or dissolved O2, leading to degradation of the samples.
β2m was selected as a model protein for studying whether covalent labeling and mass
spectrometry could identify higher order structural changes to a protein after exposure to
degradation conditions. β2m is the non-covalently bound light chain of the class I major
histocompatibility complex (MHC-I) which has 99 residues with a molecular weight of ~12 kDa.
This protein adopts the immunoglobulin fold with seven β strands forming a β-sandwich in its
native state [15]. This type of fold has similarities to monoclonal antibodies, which are important
therapeutic proteins.

5.3.2 Thermal degradation
Upon DEPC labeling of the protein β2m under normal conditions, 17 amino acids are
found to be modified. These amino acids are distributed evenly throughout the whole protein,
making it possible to monitor structural changes in most regions of the protein. Under the
covalent labeling reaction conditions we use, the protein’s structure is not damaged as
demonstrated by dose-response curves. Thus, changes in modification levels before and after
thermal degradation will indicate if the protein has undergone any structural changes due to
heating.
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Upon examining the protein after 30 min of heating at 75 ºC, our data indicate that five
side chains undergo a noticeable change in modification level when compared to a control
experiment without heating (Table 5.1). These amino acids are H13, S20, H31, S33 and K48
(Figure 5.1, residues marked with dark green and red). The DEPC modification sites and
percentages obtained under thermal degradation conditions indicate that a structural change has
occurred upon heating as compared to the native state (i.e. controls sample). A t-test is used to
demonstrate if the modification level changes are significant or not using the following equation.

Where A and B indicate two sets of data from different experiment conditions, µ is the mean
value, S is the standard deviation, and n is the number of replicates; in our case, it is three. If the
absolute t value is greater than or equal to 2, the two sets of data are significantly different at a
95% confidence level.

Table 5.1 The DEPC modification percentages of amino acids in β-2-microglobulin upon
exposure to different thermal degradation conditions. All the experiments were repeated three
times, and the means and standard deviations are reported.
Native
Heated 30
Heated 1 d
(control)
min
N-ter1
49 ± 1
50 ± 3
44 ± 2
2
K6
2.5 ± 0.1
2.5 ± 0.3
3.0 ± 0.5
S11
20 ± 3
18 ± 3
11.8 ± 0.3
H13
32 ± 2
27 ± 1
17 ± 1
K19
2.7 ± 0.4
2.5 ± 0.3
2±2
S203
1.1 ± 0.3
2.2 ± 0.3
4.8 ± 0.7
S28
0.25 ± 0.05
0.22 ± 0.05
0±0
H31
1.9 ± 0.2
1.4 ± 0.1
0.72 ± 0.08
S33
0.68 ± 0.09
0.53 ± 0.06
0±0
K41
0.6 ± 0.1
0.66 ± 0.02
1.0 ± 0.1
K48
0±0
0.34 ± 0.09
1.2 ± 0.2
H51
2.2 ± 0.3
2.5 ± 0.4
0±0
S55
1.4 ± 0.2
1.2 ± 0.1
0±0
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S57/K58
Y67/T68
K91
K94

2.5 ± 0.4
2.2 ± 0.3
2.1 ± 0.4
3.1 ± 0.6

2.8 ± 0.3
2.0 ± 0.6
2.11 ± 0.09
3.2 ± 0.1

0±0
2±1
2.0 ± 0.2
3.0 ± 0.4

1. Amino acid residues labeled in bright green indicate the modification levels decrease
significantly after 1 day thermal degradation, while those labeled in dark green indicate
the modification levels decrease significantly even after 30 min thermal degradation
2. Amino acid residues labeled in black indicate the modification levels did not change
significantly within 1 day thermal degradation
3. Amino acid residues labeled in pink indicate the modification levels increases
significantly after 1 day thermal degradation, while those labeled in red indicate the
modification level increases significantly even after 30 min thermal degradation

Figure 5.1 Structure of β2m with labeling sites marked with different colors to show changes in
modification levels upon heating for 30 min and 1 day at 75 ºC. Black: modification levels
remain constant; bright green: modification levels decrease significantly after 1 day thermal
degradation; dark green: modification levels decrease significantly after 30 min thermal
degradation; pink: modification levels increases significantly after 1 day thermal degradation;
red: modification level increases significantly after 30 min thermal degradation.
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The change of modification level could result from changes to the β strand structure. The
increase of modification percentage for some amino acids could indicate that part of the protein
structure undergoes the unfolding process due to exposure to heat, while those amino acids with
decreased modification level could suggest that more compact structure were formed. Figure 5.2
shows the modification percentage change for all the modified residues. The two sites, S20 and
K48, which show significant increase in modification level after 30 min thermal incubation
locate at B strand and C-D loop, this part of the protein are very likely to undergo the unfolding
process due to the exposure to heat. While the residues that show significant decrease in
modification level locate mainly on A-B loop and B-C loop. This part of the protein probably
formed a more compact structure after heat.

Figure 5.2 DEPC modification percentage changes of amino acid residues after heating for 30
min (green) or 1 day at 75 ºC (blue) as compared to native conditions. Positive modificaiton level
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change indicate the increase of modification percentage, while negative number indicate the
decrease of modification percentage.

With a longer heating time of 1 day, 12 of the 17 side chains are found to undergo
notable changes in modification levels. As an example, the modification percentage of H13
changes from 32 ± 2 % under native conditions to 17 ± 1 % after the protein is heated for 1 d. A
close look at the data listed in Table 5.1 demonstrates that most of the amino acids (9 out of 17)
that undergo a change in modification level show a decrease in the modification percentage,
while only 3 amino acids (i.e. S20, K41, and K48) have increased modification extents. The
increased modification percentages of these three residues are likely due to partial unfolding of
the protein. These regions are B strand and C-D loop. While the residues that show significant
decrease in modification level after 1 day thermal incubation locate mainly on A-B loop, B-C
loop, D strand and D-E loop. This part of the protein probably formed a more compact structure.
The decrease of modification levels for nine of the residues might suggest that some
aggregation of the protein has occurred. Indeed, protein aggregation is a common problem
encountered during manufacture and storage of proteins [16]. This aggregation is a major
concern for biopharmaceutical products because they may be associated with decreased
bioactivity. The aggregation of protein can be caused by various factors, such as elevated
temperature, exposure to air, mechanical stress, protein concentration and so on. Although no
precipitation was observed in the protein solution after heating for 1 day, aggregation could still
have occurred given the low protein concentration that was used. In order to check whether any
aggregation happened, size-exclusion chromatography (SEC) was used to monitor this process.
The SEC chromatograms show that besides the monomer of β2m (retention time at 10.5 min),
some dimers (retention time at 9.4 min) are formed upon thermal degradation. Figure 5.1 shows
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the structure of β2m with labeling sites marked with different colors. The residues that under a
decrease in modification level upon heating for 1 day are indicated in both bright and dark green.
These particular residues are located close to one another in space, which might indicate that this
part of the protein becomes buried upon aggregation. The residues that are shown in green are
predominantly found in the A-B loop, B-C loop, D strand and D-E loop. These regions are very
likely locate in the interface of dimer. While compared with the pre-amyloid dimer of β2m [17],
some regions are consistent, such as A-B loop and B-C loop. While in pre-amyloid dimer of β2m,
instead of D strand and D-E loop, E strand located in the interface. The modification level
changes under the different heating conditions are further shown in Figure 5.4.

Figure 5.3 β2m aggregations under thermal conditions monitored by SEC.
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Figure 5.4 DEPC modification percentages of amino acid residues after heating for 30 min or 1
day at 75 ºC as compared to native conditions.

We also investigated the effect of heating the protein and reducing its disulfide bond.
Heating and reducing the protein is expected to distort the protein’s structure to an even greater
extent, especially for β2m as the disulfide bond keeps together the two β sheets in the protein.
Therefore, more notable modification level changes were expected. The data listed in Table 5.2
is consistent with this expectation. Modification levels change more significantly than for the
heated samples. Most of the residues (15 out of 17 amino acids) show a decrease in the
modification percentage, indicating that aggregation is occurring again in this degradation
conditions. These results indicate that covalent labeling together with MS can easily detect
significant structural changes.
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Table 5.2 The DEPC modification percentages of amino acids in β-2-microglobulin upon
exposure to different thermal degradation and TCEP reduction conditions. All the experiments
were repeated three times, and the means and standard deviations are reported.
Native
Heated 30
Heated 1 d
(control)
min/reduced
/reduce
N-ter
49 ± 1
25 ± 2
40 ± 4
K6
2.5 ± 0.1
1.8 ± 0.3
0±0
S11
20 ± 3
16 ± 2
0±0
H13
32 ± 2
24 ± 3
0±0
K19
2.7 ± 0.4
1.8 ± 0.6
0±0
S20
1.2 ± 0.3
0±0
0±0
S28
0.25 ± 0.05
0.19 ± 0.03
0±0
H31
1.9 ± 0.2
1.44 ± 0.09
0.4 ± 0.6
S33
0.68 ± 0.09
0.54 ± 0.04
0±0
K41
0.6 ± 0.1
0.46 ± 0.04
0±0
K48
0±0
0.23 ± 0.02
1.0 ± 0.1
H51
2.2 ± 0.3
1.3 ± 0.2
0±0
S55
1.4 ± 0.2
1.2 ± 0.1
0±0
S57/K58
2.5 ± 0.4
1.9 ± 0.4
0±0
Y67/T68
2.2 ± 0.3
2.2 ± 0.3
14 ± 2
K91
2.1 ± 0.4
0.9 ± 0.1
0±0
K94
3.1 ± 0.6
1.4 ± 0.2
0±0
5.3.3 Oxidative condition
β2m was also exposed to oxidation conditions, and the measured DEPC modification
levels are more significant than the changes observed during thermal degradation. A total of 14
residues undergo a change in reactivity upon exposure to 3% H2O2, while 15 residues undergo
significant changes upon exposure to 10% H2O2 (Table 5.3). Some of the amino acids were
detected to be unmodified suggesting that they became buried after oxidation of the protein. One
possible explanation is that protein forms oligomers or aggregates, and these amino acids are in
the interface of the oligomers/aggregates. Separate SEC experiments (figure 5.5) show that β2m
dimers are observed. Upon oxidation, several regions of the protein show decreased levels of
modification, including from the N-ter to K19, S28 to K41, H51 to K58 and K91 to K94, which
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are locate at A strand, A-B loop, B-C loop, C and D strands, D-E loop and G strand. (Figures 5.6
and 5.7).

Figure 5.5 β2m aggregations under oxidative conditions monitored by SEC.

Although β2m aggregates under both thermal and oxidative conditions, the protein
regions that become buried are not exactly the same. The region around residues K91 and K94,
which is the G strand, does not undergo a change in modification level upon thermal degradation,
while it significantly decreases in modification extent upon oxidative degradation. Compare both
the thermal and oxidative data, more residues show a decrease in modification percentage in
oxidative incubation, and this is consistent with the SEC data that more dimers are formed under
this condition. These data conclude that covalent labeling not only can monitor protein structural
change during degradation process, but also can provide some insight about the structure of the
aggregated complex.

133

Figure 5.6 Structure of β2m with labeling sites marked with different colors to show changes in
modification levels upon oxidative conditions. Black: modification levels remain constant; bright
green: modification levels decrease significantly upon exposure to 10% H2O2; dark green:
modification levels decrease significantly upon exposure to 3% H2O2; red: modification level
increases significantly upon exposure to 3% H2O2.

Table 5.3 The DEPC modification percentages of β-2-microglobulin upon exposure to oxidative
degradation conditions. All the experiments were repeated three times, and the means and
standard deviations are reported.
Native (control) 3% H2O2
10% H2O2
N-ter
49 ± 1
7.6 ± 0.3
4.8 ± 0.4
K6
2.5 ± 0.1
0±0
0±0
S11
20 ± 3
6±2
4.0 ± 0.8
H13
32 ± 2
4±1
2.5 ± 0.2
K19
2.7 ± 0.4
0±0
0±0
S20
1.1 ± 0.3
1.7 ± 0.3
1.5 ± 0.1
S28
0.25 ± 0.05
0.30 ± 0.09
0±0
H31
1.9 ± 0.2
0.3 ± 0.1
0.31 ± 0.06
S33
0.68 ± 0.09
0.18 ± 0.01
0±0
K41
0.6 ± 0.1
0±0
0±0
K48
0±0
0±0
0±0
H51
2.2 ± 0.3
0.27 ± 0.07
0.4 ± 0.2
S55
1.4 ± 0.2
0±0
0±0
S57/K58 2.5 ± 0.4
0±0
0±0
Y67/T68 2.2 ± 0.3
6±2
12 ± 2
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K91
K94

2.1 ± 0.4
3.1 ± 0.6

0.1 ± 0.2
0.2 ± 0.3

0±0
0±0

Figure 5.7 DEPC modification percentage changes of amino acid residues after incubation with
3% H2O2 (green) or 10% H2O2 (blue) for 1 day at room temperature as compared to native
conditions. Positive modificaiton level change indicate the increase of modification percentage,
while negative number indicate the decrease of modification percentage.
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Figure 5.8 DEPC modification percentages of amino acid residues after exposure to 3% H2O2 or
10% H2O2 for 1 day at room temperature as compared to native conditions.

5.4 Conclusions
Covalent labeling combined with MS was applied to monitor protein structural changes
after exposure to thermal and oxidative degradation conditions. Results from β2m indicate that
this technique is very sensitive to protein structural changes. Significant modification percentage
changes were observed under the conditions used when compared to control conditions. Under
harsh thermal and oxidative degradation conditions, several different amino acids show a
decrease in modification level, indicating that aggregation could occur. SEC data support this
idea. Under mild thermal degradation conditions, only minimal changes in covalent labeling are
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observed, implying that the protein is undergoing on minor structural changes. Overall, this
method appears to be a sensitive way for monitoring protein structural changes under forced
degradation conditions.
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CHAPTER 6
SUMMARY AND FUTURE DIRECTIONS
6.1 Summary
This dissertation has described the development of methods to improve covalent labeling
and mass spectrometry (MS) as a tool to study the three dimensional structure of proteins.
Covalent labeling/MS as a method involves covalent modification of specific amino acid side
chains that are solvent exposed and identification of the modified residues by LC-MS/MS.
Covalent labeling is a powerful approach for monitoring conformational changes of proteins and
for studying protein-protein interactions. This dissertation describes the improvement of
diethylpyrocarbonate (DEPC)-based covalent labeling for increased protein structural resolution,
the discovery of covalent label scrambling in solution and ways to avoid it, and the use of
tandem mass tags for faster structural analysis of proteins. This improved technique is then
applied to study the structural change of proteins that undergo forced degradation.
The combination of DEPC-based covalent modification and MS detection has been
improved and optimized for the structural analysis of proteins. DEPC-modified amino acids were
found to be more labile than previously thought based on the study of several peptides and
proteins. This lability can lead to loss of protein structural information. Label loss is very
significant for Ser, Thr, Tyr and His residues. Several methods for shortening the time between
the covalent labeling reaction and the MS analysis were investigated. The number of
modification sites identified after labeling with DEPC can be increased by shortening the time
between the reaction and analysis, and this greater number of labeled sites provides increased
structural resolution. Several methods were investigated, including microwave and ultrasonic
assisted digestions, immobilized chomotrypsin, and middle-down sequencing using Glu-C.
Microwave and ultrasonic assisted digestions not only accelerate protein digestion but were
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found to also accelerate hydrolysis to a greater extent, resulting in lower measured modification
levels. A 2-hour immobilized chymotrypsin digestion was found to be superior for obtaining
more structural information for the proteins we studied. Middle-down sequencing using Glu-C
provided the most extensive labeling information: the number of labeled sites increases by 1.5fold for cytochrome c and 2-fold for myoglobin. The improved method can provide more reliable
information in protein surface structure. Because DEPC also only produces a single reaction
product, thereby simplifying the MS analysis, it may serve as a viable alternative to hydroxyl
radical footprinting.
Once added, covalent labels are generally considered to be stable. In other words,
scrambling is not generally thought to occur with this technique as with hydrogen/deuterium
exchange. Our experiments show, however, that cysteine residues can capture carbethoxy groups
from other modified amino acids. This process leads to incorrect structural information about a
protein and also accelerates the loss DEPC modifications from certain amino acids, especially
His, Ser, Thr and Tyr residues, which results in less structural information. Therefore, it is
important to avoid the transfer of carbethoxy groups to cysteine. This was most effectively
accomplished by adding iodoacetamide to cap the free cysteines after disulfide reduction, so that
transfer of the carbethoxy groups from modified residues to cysteines is prevented. We predict
that although the described results are specific for DEPC labeling, other electrophilic labeling
reagents could conceivably exhibit similar scrambling behavior, given the high reactivity of
thiols with electrophiles.
For covalent labeling experiments, it is very important to make sure that the structural
integrity of a protein is preserved during the reaction so that the structural information obtained
from covalent labeling is reliable. Measuring the kinetics of the covalent labeling reactions
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ensures that the covalent reagent does not distort a protein’s structure during the labeling reaction.
Dose-response plots are a sensitive way to monitor any modification-induced structural changes
caused by the covalent labels; however, this method is laborious and sample intensive. We
developed a new strategy that uses isotopically encoded covalent labeling reagents to
simultaneously investigate the range of covalent labeling reagent concentrations that will provide
information about the surface structure of the protein while avoiding modification-induced
structural changes. For this purpose, tandem mass tags (TMTs) were used to isotopically encode
the desired reactivity information, and MS/MS was used to generate reporter ions that provide a
readout of a given site’s reactivity with the covalent labeling reagent. The new approach is not
only faster, but also requires less sample. This approach was validated by comparing it to another
more time-consuming method of ensuring protein structural integrity, and we found that the new
approach provides comparable results. In short, this new strategy represents a faster and more
efficient way to ensure the accuracy of covalent labeling/MS experiments. This strategy could be
used with other covalent labeling reagents that are isotopically labeled.
Because covalent labeling combined with MS can be used to monitor conformational
changes of proteins, we also investigated whether it could be applied to study structural changes
of proteins after exposure to degradation conditions. β2m was used as a model protein to
examine the potential of this method. Forced degradation studies using thermal and oxidative
conditions were carried out. Covalent modification patterns of the protein show clear differences
under these degradation conditions as compared to the native protein. The general trend that we
found was that less modification was observed for both thermal and oxidative condition,
indicating that aggregation could occur at higher temperatures or in the presence of hydrogen
peroxide. Size exclusion chromatography confirmed that there was dimer formation during the
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forced degradation conditions, which is consistent with the covalent labeling data. This method
could be applied to other systems to study degradation caused structural changes of proteins as it
is a fast and relatively simple approach.

6.2 Future Directions
The following sections discuss several areas of possible future research to either improve
the covalent labeling method or increase the amount of information we can obtain about β2m
amyloid formation.

6.2.1 Studying the protein chemical factors that affect DEPC modification of proteins
Covalent labeling of an amino acid in a protein is thought to depend on the solvent
accessibility of the side chain and the inherent reactivity of the label and the amino acid side
chain. [1]In fact, early work with DEPC [2]reported that the reactivity of histidine is correlated
well with the calculated solvent accessibilities of the imidazolyl nitrogen atom. No systematic
study, though, has been carried out to find how well reactivity and solvent accessibility correlate.
If reactivity can be related to a parameter such as solvent accessible surface area (SASA), then
covalent labeling reactions along with MS would be more useful for studying proteins with
unknown structures. SASA is probably the major factor influencing the reactivity of a given
amino acid, but other factors such as the side chain pKa value or the residue’s microenvironment
(e.g. nearby charged residues) will also influence reactivity to some degree.

6.2.1.1 Cataloging the reactivity of residues from numerous proteins
The relationship between amino acid reactivity and SASA can be investigated using
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numerous proteins to develop a data set big enough to draw meaningful conclusions. The
reaction rate coefficient of each amino acid could be determined using a peptide’s dose-response
plot as described earlier [3]and correlating this reactivity with the residue’s calculated SASA.
We predict that the more the amino acid side chain is exposed to the solvent, the higher
the reactivity will be for that amino acid. Since other factors such as microenvironment might
also affect the reactivity, we do not predict a perfect correlation but rather something like Figure
6.1.

Figure 6.1 Expected trend for SASA and rate coefficient.

6.2.1.2 Calculating solvent accessible surface area (SASA)
SASA for sites in a protein can be readily calculated from GETAREA using the 3D
structures of proteins obtained from the Protein Data Bank (PDB). One way to improve the
correlation between SASA and reactivity could be to test several probe radii. A probe radius of
1.4 Å, representing the van der Waals sphere of water, is most commonly used. There is at least
one problem with using this probe radius – water is not reacting with the protein. So, probe radii
that more accurately reflect the effective size of DEPC would need to be investigated. Using
chem3D to optimize the structure of DEPC, we estimate the radius of DEPC to be 4.7 Å (Figure
6.2). This value and other values between 1.4 and 4.7 Å could be used to see which probe radius
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best correlates with the experimental data.

Figure 6.2 Calculated radius of DEPC

In addition to varying the probe radius, whether the SASA of the entire side chain or just
the reacting atom best correlates with the measured reaction rate coefficients for a given type of
amino acid could also be considered. The SASA of the entire side chain may reflect the overall
reactivity, but the solvent accessibility of the reactive atom might be a better indicator, because
the atom directly reacts with DEPC.
A third issue to consider is that the SASA calculated from GETAREA is from the static
protein, which may not be accurate because proteins are dynamic. In order to address this issue,
molecular dynamics calculations using Gromacscould be investigated to calculate more accurate
SASA values. Gromacsis a versatile collection of programs and libraries for simulating the
molecular dynamics of proteins and analyzing the subsequent trajectory data.[4] One of the
analysis tools in Gromacs allows one to compute average SASA values of functional groups in
macromolecules using multiple protein structures from a molecular dynamics simulation. SASA
values obtained in this way could be more accurate than those obtained from static crystal
structures.

6.2.1.3 Microenvironment
While SASA values will correlate fairly well with reactivity, we predict that the
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microenvironment around the amino acid residue could play an important role in the extent of a
residue’s modification. Three aspects of amino acid microenvironment could be investigated to
determine how this factor influences reactivity with DEPC. First, we could examine whether or
not an amino acid’s ability to form a salt bridge affects its reactivity. Second, we could
investigate if an amino acid’s calculated pKa value correlates with its reactivity. Third, we could
test if nearby charged residues enhance the reactivity of certain residues, such as serine and
threonine residues, which are only reactive with DEPC in some proteins.
Salt bridges are actually a combination of two non-covalent interactions: hydrogen
bonding and electrostatic interactions. Among the amino acids that can be modified by DEPC,
lysine is most likely to form salt bridges with the carboxylates of aspartic and glutamic acids;
however, ionized histidine residues can also take part. Thesenoncovalent interactionscould
influence the nucleophilicity of the lysine side chain, and therefore change the reactivity of this
group compared with an amino acid that does not form a salt bridge. The distance between the
residues participating in the salt bridges is also important to consider as residues that are
involved in salt bridges might also be sterically hindered from reacting with DEPC. The distance
between salt bridges are typically less than 4 Å,[5] but these relatively long-range interactions
have no preferred orientation. As a result, some residues involved in salt bridges may be less
sterically hindered than others. Lysine residues could be used to study the effect of salt bridge
formation on reactivity with DEPC.
It’s very possible that a residue’s pKa value will also influence its reactivity with DEPC.
Amino acids with lower pKa values are more likely to be deprotonated at a given pH, and
because deprotonated amino acids tend to be stronger nucleophiles, we expect these amino acids
to have higher reaction rate coefficients. To test this hypothesis, the pKa values of all reactive
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residues could be calculated and comparedwith their measured reaction rate coefficients. Amino
acid pKa values can be estimated using a web-based program called PROPKA.
As listed in chapter 2, no DEPC modification of serines and threonines were observed for
peptides that contain these two residues. Serine and threonine residues, however, were observed
to be modified in some proteins. Therefore, it would be very interesting to test if nearby charged
residues enhance the reactivity of serine and threonine residues. One possible explanation is that
the serine and threonine residues form hydrogen bonds with carboxylates of aspartic and
glutamic acids (see figure 6.3), thereby increasing the nucleophilicity and thus reactivity of the
oxygen atoms of Ser and Thr.
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Figure 6.3 Hydrogen bond formation between serine and Asp or Glu increases the reactivity of
oxygen atoms

Overall, investigating the protein chemical factors that affect the reactions of amino acids
with DEPC would allow us to better apply the covalent labeling approach to study protein
structure. If factors other than SASA are found to influence DEPC reactivity, then these factors
could be used to get more detailed information about a protein’s structure. For example, if a
nearby negative charge is found to allow certain Ser residues to react with DEPC, then the
observation of such reactions would provide additional information about the electrostatic
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environment of the protein around that residue.

6.2.2 Top-down mass spectrometry for locating covalent labeling sites
Chapter 2 demonstrates that information obtained with DEPC can be substantially
increased if the time between the covalent labeling reaction and MS analysis is reduced.
Immobilized enzyme digestion and middle-down sequencing can decrease the time to several
hours, however, if this time can be further shortened to several minutes, it may be possible to
find even more modification sites. Top-down sequencing is a possible method for this purpose
because it can be performed immediately after the labeling reaction is done.
To use top-down sequencing for this purpose, however, several problems need to be
solved. The first one is whether top-down sequencing can provide quantitative or semiquantitative information about the extent of modification. ETD and ECD are the major
fragmentation techniques that are used for top-down experiments. Although ETD and ECD
dissociation patterns are less affected by amino acid side chain chemistry than CID, there is no
guarantee that ETD and ECD will provide accurate quantitative information about covalent
modification levels for the peptides and proteins. The second problem is how to get good
fragmentation efficiency, especially for large proteins. Some potential solutions are to denature
the protein, break disulfide bonds, and increase the charge state by using supercharging reagents
[6-10].

6.2.3 Ion mobility for oligomer structure studies
Protein amyloid formation involves the conversion of native proteins into ordered protein
aggregates and is implicated in close to 20 human diseases. While many efforts have been made
to investigate the molecular details of amyloid formation, the early stages of this process are not
clear. Our lab has been interested in the pre-amyloid oligomers of β-2-microglobulin (β2m),
which forms amyloid fibrils in dialysis-related amyloidosis. Based on our previous work, Cu(II)
is known to induce the formation of dimers, tetramers and hexamers of β2m prior to forming
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amyloid fibrils. Other divalent metals, such as Zn(II) and Ni(II) do not enable amyloid
formation, but Zn(II) does induce the formation of oligomers. Covalent labeling combined with
mass spectrometry can provide some insight of the oligomer formation process, but ion mobility
spectrometry could be used as an complementary tool to study how these different metals
influence the conformations of β2m.In addition, ion mobility could help identify any isomeric
structural forms of these oligomers, especially the tetramer, which is known to have different
forms in solution.
Trapped ion mobility spectrometry (TIMS) is a new technique that allows analytes to be
distinguished on the basis of their mass, charge and collision cross section (i.e., size and shape)
(see figure 6.4).In TIMS, ions are radially confined by RF voltages while axially trapped by the
balance between gas flow and a retarding DC electric field. Reducing the retarding field over
time elutes ions in accordance with their mobility. By applying TIMS to different samples
containing different metals and β2m, we should be able to get some insight into the effects of
different metals on β2m oligomerization and amyloid formation.
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Figure 6.4 Trapped ion mobility spectrometry (TIMS) [11]A.TIMS funnel including capillary,
deflection plate, entrance funnel analyzer section, and exit funnel; B. DC potential as a function
of position in the TIMS funnel during transmission only and trapping for mobility analysis; C.
Potentials vs. position during the TIMS analysis; and D. Field strength vs. position during the
TIMS analysis
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Some preliminary experiments have been performed with TIMS. β2m can be induced to
form oligomers and eventually amyloid fibrils when incubated with stoichiometric amounts of
Cu(II) under otherwise physiological conditions (pH 7.4, 37 ºC, 150 mM potassium acetate).
β2m was also induced to form oligomers but not amyloid fibrils by incubating the protein with
Zn(II) under similar conditions. Incubation of the protein for different time periods allows the
progressive formation of different oligomers. Size exclusion chromatography (SEC) was used to
monitor oligomer formation.
Desalted samples of incubated β2m are electrosprayed and TIMS spectra of the
monomer, dimer and tetramer can be obtained. The ion mobility distribution of the monomer
shows two peaks: one dominant peak and one less abundant peak (figure 6.5). One of these
conformers may be the fully folded form of the protein and the other could be a partially
unfolded form that is able to form oligomers. The reduced mobilities (k0) and cross section (Ω)
of the monomer (+7; m/z 1676) with a 1 ms delay is listed in table 6.1. From the NMR structure
of β2m [12],the calculated surface area is 6723 Å2, which corresponds to a cross section of about
1680 Å2, which is comparable to the calculated cross sections from k0. When bound to different
metal ions, the monomer shows different mobilities, or similar mobilities with different amounts
of each conformation, indicating structural differences in some cases. Incubation with Ni(II)
seems to extend the protein structure or impede the formation of a compact structure more than
other metals. A correlation can be found between the presence of conformations with smaller
cross sections and the ability to form β2m dimers. Besides, longer trapping times (50 ms vs. 1
ms) lead to better resolution, presumably due to better desolvation.

Table 6.1 Reduced mobilities (k0) and cross section (Ω) of monomer (+7 m/z 1676) with a 1 ms
delay
Major peak

k

Minor peak

Ω (Å )
k

0
2

0

2

Ω (Å )

no metal
0.93 ± 0.01

with Cu(II)
0.94 ± 0.02

with Zn(II)
0.96 ± 0.01

with Ni(II)
0.85 ± 0.01

1470 ± 15

1460 ± 35

1425 ± 20

1610 ± 20

0.836 ± 0.001

0.84 ± 0.01

0.855 ± 0.003

---

1638 ± 2

1630 ± 20

1603 ± 6

---
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Figure 6.5 Ion mobility spectra of +7 monomer for β2m
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β2m dimers were produced by three different means: (i) incubation with Cu(II), which
allows eventual amyloid formation; (ii) incubation with Zn(II), which does not enable eventual
amyloid formation; and (iii) in a non-specific manner using relatively high concentrations during
electrospray ionization. TIMS spectra of the dimers produced by each method show that three
protein distributions are present in each case, but the distributions have subtle differences,
depending on the method used to generate the dimers (figure 6.6). Table 6.2 lists the reduced
mobilities (k0) and cross sections (Ω) of dimer (+11; m/z 2133) with a 1 ms delay. These results
suggest that the dimer structures may be slightly different in each case, which is consistent with
the different reaction outcome (i.e. amyloid or no amyloid) in each case. Variations in the storage
time of the protein in the mobility region of the device indicate that the protein forms collapse
into a single distribution. Preliminary data suggests that this collapse into a single structure could
be due to the non-specific association of another protein unit to the dimer or the conversion of
one isomeric form to another.
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Figure 6.6 Ion mobility spectra of the +11 dimer of β2m

Table 6.2 Reduced mobilities (k0) and cross sections (Ω) of the dimer (+11; m/z 2133) with a 1
ms delay:
st

1 peak

k

0
2

nd

2 peak

Ω (Å )
k
0

2

Ω (Å )

no metal
0.807 ± 0.006

with Cu (II)
0.81 ± 0.02

with Zn(II)
0.822 ± 0.009

2670 ± 20

2650 ± 60

2620 ± 30

0.91 ± 0.01

0.930 ± 0.003

0.958 ± 0.005

2360 ± 40

2314 ± 6

2240 ± 10
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Further experiments are need to explore the following topics: (1) how trapping time
influences resolution; (2)optimize ESI conditions to obtain ion mobility data for tetramer I and
tetramer II and compare mobility patterns for these oligomers; (3) study the β2m hexamer by ion
mobility. TIMS could potentially provide very useful information to understand the
oligomerization process as well as the influence of different metals on β2m’s structure.
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